@NP	Efficacy	1
@NP	olfactory ensheathing cells	13
@NP	regeneration	52
@NP	spinal cord injury	71
@NP	method of culture preparation Liudmila N.	107
@NP	method	107
@NP	culture preparation Liudmila N.	117
@NP	Novikova a , Sergei Lobov a , Mikael Wiberg a , b , Lev N.	150
@NP	Novikova a , Sergei Lobov	150
@NP	Novikova a	150
@NP	Sergei Lobov	162
@NP	a , Mikael Wiberg a , b , Lev N.	175
@NP	a	175
@NP	Mikael Wiberg a	178
@NP	Mikael Wiberg	178
@NP	a	192
@NP	b , Lev N.	194
@NP	b	194
@NP	Lev N.	197
@NP	Novikov a	204
@NP	a Department	216
@NP	Integrative Medical Biology	232
@NP	Section	261
@NP	Anatomy	272
@NP	Umeå University	281
@NP	SE-901 87 Umeå	298
@NP	Sweden b Department of Surgical	314
@NP	Sweden b Department	314
@NP	Surgical	337
@NP	Perioperative Science	350
@NP	Section of Hand	373
@NP	Section	373
@NP	Hand	384
@NP	Plastic Surgery , Umeå University , SE-901 87 Umeå , Sweden a b	393
@NP	Plastic Surgery	393
@NP	Umeå University	410
@NP	SE-901 87 Umeå	427
@NP	Sweden a b	443
@NP	Sweden	443
@NP	a b	452
@NP	t r	458
@NP	a c t Olfactory ensheathing cells -LRB- OEC -RRB-	462
@NP	a c t Olfactory ensheathing cells	462
@NP	a c t	462
@NP	Olfactory ensheathing cells	468
@NP	OEC	497
@NP	regeneration , myelination and functional recovery	531
@NP	different spinal cord injury models	584
@NP	recent reports from several laboratories	630
@NP	recent reports	630
@NP	several laboratories	650
@NP	this treatment strategy	687
@NP	The discrepancy in results	712
@NP	The discrepancy	712
@NP	results	731
@NP	many factors including variations in culture protocols	762
@NP	many factors	762
@NP	variations in culture protocols	785
@NP	variations	785
@NP	culture protocols	799
@NP	The present study	818
@NP	the differences in culture preparation	857
@NP	the differences	857
@NP	culture preparation	876
@NP	neuroprotective and growth-promoting effects of OEC	912
@NP	neuroprotective and growth-promoting effects	912
@NP	OEC	960
@NP	transplantation	970
@NP	the injured spinal cord	991
@NP	Primary OEC cultures	1016
@NP	method of differential cell adhesion -LRB- a-OEC -RRB-	1057
@NP	method	1057
@NP	differential cell adhesion -LRB- a-OEC -RRB-	1067
@NP	differential cell adhesion	1067
@NP	a-OEC	1095
@NP	immunomagnetic beads -LRB- b-OEC -RRB-	1120
@NP	immunomagnetic beads	1120
@NP	b-OEC	1142
@NP	cervical C4 hemisection in adult rats	1156
@NP	cervical C4 hemisection	1156
@NP	adult rats	1183
@NP	short-term -LRB- 3 weeks -RRB- or long-term -LRB- 7 weeks -RRB- cultured OEC	1195
@NP	short-term -LRB- 3 weeks -RRB-	1195
@NP	short-term	1195
@NP	3 weeks	1207
@NP	long-term -LRB- 7 weeks -RRB- cultured OEC	1219
@NP	long-term -LRB- 7 weeks -RRB-	1219
@NP	long-term	1219
@NP	7 weeks	1230
@NP	OEC	1248
@NP	the lateral funiculus at 1 mm rostral and caudal	1275
@NP	the lateral funiculus	1275
@NP	1 mm rostral and caudal	1300
@NP	1 mm rostral	1300
@NP	caudal	1317
@NP	the transection site	1327
@NP	3	1352
@NP	8 weeks after transplantation , labeled OEC	1354
@NP	8 weeks	1354
@NP	transplantation , labeled OEC	1368
@NP	transplantation	1368
@NP	OEC	1393
@NP	the injection sites	1418
@NP	the trauma zone	1445
@NP	Short-term cultured a-OEC	1462
@NP	Short-term	1462
@NP	a-OEC	1482
@NP	regrowth of rubrospinal , raphaespinal and CGRP-positive fibers	1498
@NP	regrowth	1498
@NP	rubrospinal , raphaespinal and CGRP-positive fibers	1510
@NP	retrograde degeneration	1577
@NP	the red nucleus	1604
@NP	Shortterm cultured b-OEC	1621
@NP	Shortterm	1621
@NP	b-OEC	1640
@NP	axonal regrowth	1664
@NP	the density of rubrospinal axons	1694
@NP	the density	1694
@NP	rubrospinal axons	1709
@NP	the dorsolateral funiculus	1734
@NP	significant neuroprotection	1774
@NP	axotomized rubrospinal neurons	1806
@NP	addition	1841
@NP	short-term cultured OEC	1851
@NP	short-term	1851
@NP	OEC	1871
@NP	rubrospinal terminals	1899
@NP	contrast	1925
@NP	long-term	1935
@NP	OEC	1954
@NP	axonal growth	1975
@NP	retrograde cell death	2003
@NP	The results	2026
@NP	the age of OEC in culture and the method of cell purification	2051
@NP	the age	2051
@NP	OEC in culture and the method of cell purification	2062
@NP	OEC in culture	2062
@NP	OEC	2062
@NP	culture	2069
@NP	the method of cell purification	2081
@NP	the method	2081
@NP	cell purification	2095
@NP	the efficacy of OEC	2126
@NP	the efficacy	2126
@NP	OEC	2142
@NP	neuronal survival and regeneration	2157
@NP	spinal cord injury	2198
@NP	This article	2218
@NP	part of a Special Issue entitled	2234
@NP	part	2234
@NP	a Special Issue entitled	2242
@NP	a Special Issue	2242
@NP	olfactory ensheathing glia and their prospect for nervous system repair	2282
@NP	olfactory ensheathing glia	2282
@NP	their prospect for nervous system repair	2313
@NP	their prospect	2313
@NP	nervous system repair	2332
@NP	Introduction	2356
@NP	the adultmammalian spinal cord	2372
@NP	damage to nervefibers	2404
@NP	damage	2404
@NP	nervefibers	2414
@NP	nearly complete failure of the severed axons to regenerate	2437
@NP	nearly complete failure	2437
@NP	the severed axons to regenerate	2464
@NP	Pathology of the spinal injury	2497
@NP	Pathology	2497
@NP	the spinal injury	2510
@NP	the initial mechanical insult	2554
@NP	secondary processes including ischemia and cell death	2597
@NP	secondary processes	2597
@NP	ischemia and cell death	2627
@NP	cyst formation and enlargement of the trauma zone	2678
@NP	cyst formation and enlargement	2678
@NP	the trauma zone	2712
@NP	Cytokines , free radicals and nitric oxide generated by microglia	2729
@NP	Cytokines	2729
@NP	free radicals	2740
@NP	nitric oxide generated by microglia	2758
@NP	nitric oxide	2758
@NP	microglia	2784
@NP	reactive astrocytes	2804
@NP	proteoglycans	2835
@NP	glial scar -LRB- Busch et al. , 2010 ; Fitch and Silver , 2008 -RRB-	2861
@NP	glial scar	2861
@NP	Busch	2873
@NP	et al. , 2010 ; Fitch and Silver , 2008	2879
@NP	et al.	2879
@NP	2010 ; Fitch and Silver	2887
@NP	2010	2887
@NP	Fitch and Silver	2893
@NP	2008	2911
@NP	addition	2921
@NP	retrograde degeneration	2931
@NP	the lesioned spinal tracts	2965
@NP	Deumens et al. , 2005	2993
@NP	Deumens	2993
@NP	et al.	3001
@NP	2005	3009
@NP	axons	3024
@NP	inhibitory nature of myelin and the glial scar	3045
@NP	inhibitory nature	3045
@NP	myelin and the glial scar	3066
@NP	myelin	3066
@NP	the glial scar	3077
@NP	little functional recovery	3128
@NP	Boulenguez and Vinay , 2009 ; Bunge , 2008 ; Tetzlaff et al. , 2010	3156
@NP	Boulenguez and Vinay	3156
@NP	Boulenguez	3156
@NP	Vinay	3171
@NP	2009 ; Bunge	3178
@NP	2009	3178
@NP	Bunge	3184
@NP	2008 ; Tetzlaff et al. , 2010	3191
@NP	2008	3191
@NP	Tetzlaff et al. , 2010	3197
@NP	Tetzlaff	3197
@NP	et al. , 2010	3206
@NP	et al.	3206
@NP	2010	3214
@NP	regeneration	3232
@NP	spinal cord injury	3251
@NP	several challenging objectives	3271
@NP	inhibitory signals	3334
@NP	the trauma zone	3356
@NP	secondary degeneration , scarring and cavitation	3382
@NP	secondary degeneration	3382
@NP	scarring	3406
@NP	cavitation	3419
@NP	spinal cord tissue gaps	3440
@NP	axonal growth	3487
@NP	the lesion site	3508
@NP	Experimental data	3525
@NP	different treatment strategies	3557
@NP	modification	3598
@NP	inhibitory extracellular matrix molecules	3614
@NP	transplants of embryonic nervous tissue and glial cells	3657
@NP	transplants	3657
@NP	embryonic nervous tissue and glial cells	3672
@NP	embryonic nervous tissue	3672
@NP	glial cells	3701
@NP	nerve grafts and neurotrophic factors	3723
@NP	nerve grafts	3723
@NP	neurotrophic factors	3740
@NP	principle	3771
@NP	regeneration	3792
@NP	injured central nerve tracts	3808
@NP	Bunge	3838
@NP	2008	3845
@NP	Fortun	3851
@NP	et al. , 2009 ; Kocsis et al. , 2009 ; Lu and Tuszynski , 2008 ; Tetzlaff et al.	3858
@NP	et al. , 2009	3858
@NP	et al.	3858
@NP	2009	3866
@NP	Kocsis et al. , 2009	3872
@NP	Kocsis	3872
@NP	et al. , 2009	3879
@NP	et al.	3879
@NP	2009	3887
@NP	Lu and Tuszynski , 2008	3893
@NP	Lu and Tuszynski	3893
@NP	2008	3911
@NP	Tetzlaff et al.	3917
@NP	Tetzlaff	3917
@NP	et al.	3926
@NP	2010	3934
@NP	promising effects	3952
@NP	axonal regeneration and neuronal survival after spinal cord injury	3973
@NP	axonal regeneration and neuronal survival	3973
@NP	spinal cord injury	4021
@NP	transplantation	4065
@NP	a certain glial cell type	4084
@NP	the olfactory ensheathing cells -LRB- OEC -RRB-	4111
@NP	the olfactory ensheathing cells	4111
@NP	OEC	4144
@NP	Fouad	4150
@NP	et al. , 2009a	4156
@NP	et al.	4156
@NP	2009a	4164
@NP	Franssen et al. , 2007	4171
@NP	Franssen	4171
@NP	et al. , 2007	4180
@NP	et al.	4180
@NP	2007	4188
@NP	Kocsis et al. , 2009	4194
@NP	Kocsis	4194
@NP	et al. , 2009	4201
@NP	et al.	4201
@NP	2009	4209
@NP	Lindsay et al. , 2010	4215
@NP	Lindsay	4215
@NP	et al. , 2010	4223
@NP	et al.	4223
@NP	2010	4231
@NP	Munoz-Quiles et al. , 2009	4237
@NP	Munoz-Quiles	4237
@NP	et al. , 2009	4250
@NP	et al.	4250
@NP	2009	4258
@NP	Radtke and Wewetzer , 2009	4264
@NP	Radtke and Wewetzer	4264
@NP	2009	4285
@NP	Raisman et al. , 2011	4291
@NP	Raisman	4291
@NP	et al. , 2011	4299
@NP	et al.	4299
@NP	2011	4307
@NP	Richter and Roskams , 2008	4313
@NP	Richter and Roskams	4313
@NP	2008	4334
@NP	the mechanisms of growth-promoting and neuroprotective effects of OEC	4350
@NP	the mechanisms	4350
@NP	growth-promoting and neuroprotective effects of OEC	4368
@NP	growth-promoting and neuroprotective effects	4368
@NP	OEC	4416
@NP	It	4451
@NP	OEC	4474
@NP	various neurotrophic factors	4486
@NP	Lipson	4516
@NP	et al. , 2003 ; Pastrana et al. , 2007	4523
@NP	et al.	4523
@NP	2003 ; Pastrana et al.	4531
@NP	2003	4531
@NP	Pastrana et al.	4537
@NP	Pastrana	4537
@NP	et al.	4546
@NP	2007	4554
@NP	proteins which indirectly stimulate Schwann cells to support neurite outgrowth	4569
@NP	proteins	4569
@NP	Schwann cells	4605
@NP	neurite outgrowth	4630
@NP	spinal cord repair -LRB- Au et al. , 2007 -RRB-	4660
@NP	spinal cord repair	4660
@NP	Au	4680
@NP	et al. , 2007	4683
@NP	et al.	4683
@NP	2007	4691
@NP	contrast to Schwann cells	4705
@NP	contrast	4705
@NP	Schwann cells	4717
@NP	astrocytes	4749
@NP	their hypertrophy -LRB- Lakatos et al. , 2000 ; Santos-Silva et al. , 2007 -RRB-	4777
@NP	their hypertrophy	4777
@NP	Lakatos	4796
@NP	et al. , 2000 ; Santos-Silva et al. , 2007	4804
@NP	et al.	4804
@NP	2000 ; Santos-Silva et al.	4812
@NP	2000	4812
@NP	Santos-Silva et al.	4818
@NP	Santos-Silva	4818
@NP	et al.	4831
@NP	2007	4839
@NP	it	4855
@NP	individual therapies	4882
@NP	a panacea for spinal cord repair	4927
@NP	a panacea	4927
@NP	spinal cord repair	4941
@NP	a combinations of strategies	4971
@NP	a combinations	4971
@NP	strategies	4989
@NP	improvements in outcome	5014
@NP	improvements	5014
@NP	outcome	5030
@NP	spinal injury -LRB- Bunge , 2008 ; Lu and Tuszynski , 2008 -RRB-	5044
@NP	spinal injury	5044
@NP	Bunge , 2008 ; Lu and Tuszynski , 2008	5059
@NP	Bunge	5059
@NP	2008 ; Lu and Tuszynski	5066
@NP	2008	5066
@NP	Lu and Tuszynski	5072
@NP	2008	5090
@NP	The growth-promoting effect of OEC	5097
@NP	The growth-promoting effect	5097
@NP	OEC	5128
@NP	OECs	5177
@NP	Schwann cells and chondroitinase treatment	5187
@NP	Schwann cells	5187
@NP	chondroitinase treatment	5205
@NP	inhibition	5242
@NP	the glial scar -LRB- Bretzner et al. , 2010 ; Fouad et al. , 2009b -RRB-	5256
@NP	the glial scar	5256
@NP	Bretzner	5272
@NP	et al. , 2010 ; Fouad et al. , 2009b	5281
@NP	et al.	5281
@NP	2010 ; Fouad et al.	5289
@NP	2010	5289
@NP	Fouad et al.	5295
@NP	Fouad	5295
@NP	et al.	5301
@NP	2009b	5309
@NP	It	5317
@NP	OEC	5352
@NP	degeneration of axotomized descending neurons	5370
@NP	degeneration	5370
@NP	axotomized descending neurons	5386
@NP	spinal cord injury -LRB- Xiao et al. , 2005 -RRB- and retinal ganglion cells	5422
@NP	spinal cord injury -LRB- Xiao et al. , 2005 -RRB-	5422
@NP	spinal cord injury	5422
@NP	Xiao	5442
@NP	et al. , 2005	5447
@NP	et al.	5447
@NP	2005	5455
@NP	retinal ganglion cells	5465
@NP	optic nerve lesion -LRB- Wu et al. , 2010 -RRB-	5494
@NP	optic nerve lesion	5494
@NP	Wu	5514
@NP	et al. , 2010	5517
@NP	et al.	5517
@NP	2010	5525
@NP	the growing number of reports	5546
@NP	the growing number	5546
@NP	reports	5568
@NP	the efficacy of OEC	5591
@NP	the efficacy	5591
@NP	OEC	5607
@NP	spinal cord repair	5622
@NP	Aoki	5642
@NP	et al. , 2010	5647
@NP	et al.	5647
@NP	2010	5655
@NP	Barakat et al. , 2005	5661
@NP	Barakat	5661
@NP	et al. , 2005	5669
@NP	et al.	5669
@NP	2005	5677
@NP	Bretzner et al. , 2010	5683
@NP	Bretzner	5683
@NP	et al. , 2010	5692
@NP	et al.	5692
@NP	2010	5700
@NP	Collazos-Castro et al. , 2005	5706
@NP	Collazos-Castro	5706
@NP	et al. , 2005	5722
@NP	et al.	5722
@NP	2005	5730
@NP	Lu et al. , 2006	5736
@NP	Lu	5736
@NP	et al. , 2006	5739
@NP	et al.	5739
@NP	2006	5747
@NP	Steward et al. , 2006	5753
@NP	Steward	5753
@NP	et al. , 2006	5761
@NP	et al.	5761
@NP	2006	5769
@NP	It	5776
@NP	functional recovery after OEC transplantation	5802
@NP	functional recovery	5802
@NP	OEC transplantation	5828
@NP	collateral sprouting	5870
@NP	collateral	5870
@NP	Bradbury and McMahon , 2006 ; Toft et al. , 2007	5892
@NP	Bradbury and McMahon	5892
@NP	2006 ; Toft et al.	5914
@NP	2006	5914
@NP	Toft et al.	5920
@NP	Toft	5920
@NP	et al.	5925
@NP	2007	5933
@NP	migrating host Schwann cells -LRB- Boyd et al. , 2005 -RRB-	5943
@NP	migrating host Schwann cells	5943
@NP	Boyd	5973
@NP	et al. , 2005	5978
@NP	et al.	5978
@NP	2005	5986
@NP	axonal regeneration across the lesion site	6007
@NP	axonal regeneration	6007
@NP	the lesion site	6034
@NP	The discrepancy in results	6051
@NP	The discrepancy	6051
@NP	results	6070
@NP	many factors	6101
@NP	the source	6124
@NP	tissue	6138
@NP	the OEC	6160
@NP	the age	6169
@NP	the purity	6181
@NP	transplanted cells	6195
@NP	the methodology used in culture preparation	6218
@NP	the methodology	6218
@NP	culture preparation	6242
@NP	Barnett and Riddell	6263
@NP	2007 ; Kawaja et al. , 2009 ; Nieto-Sampedro , 2003 ; Raisman and Li	6284
@NP	2007	6284
@NP	Kawaja et al. , 2009 ; Nieto-Sampedro , 2003 ; Raisman and Li	6290
@NP	Kawaja	6290
@NP	et al. , 2009 ; Nieto-Sampedro , 2003 ; Raisman and Li	6297
@NP	et al. , 2009	6297
@NP	et al.	6297
@NP	2009	6305
@NP	Nieto-Sampedro , 2003	6311
@NP	Nieto-Sampedro	6311
@NP	2003	6327
@NP	Raisman and Li	6333
@NP	Raisman	6333
@NP	Li	6345
@NP	2007	6349
@NP	the type	6366
@NP	spinal cord injury	6378
@NP	the timing	6398
@NP	the location of grafts within the injured spinal cord	6413
@NP	the location	6413
@NP	grafts within the injured spinal cord	6429
@NP	grafts	6429
@NP	the injured spinal cord	6443
@NP	the outcome of OEC transplantation	6488
@NP	the outcome	6488
@NP	OEC transplantation	6503
@NP	The present study	6524
@NP	OEC	6563
@NP	the adult rat olfactory bulbs	6582
@NP	a method	6630
@NP	differential adhesion -LRB- Nash et al. , 2001 ; Sasaki et al. , 2004 -RRB-	6642
@NP	differential adhesion	6642
@NP	Nash	6665
@NP	et al. , 2001 ; Sasaki et al. , 2004	6670
@NP	et al.	6670
@NP	2001 ; Sasaki et al.	6678
@NP	2001	6678
@NP	Sasaki et al.	6684
@NP	Sasaki	6684
@NP	et al.	6691
@NP	2004	6699
@NP	immunomagnetic beads	6713
@NP	Gudino-Cabrera and Nieto-Sampedro , 1996 ; Lopez-Vales et al. , 2007	6735
@NP	Gudino-Cabrera and Nieto-Sampedro	6735
@NP	1996 ; Lopez-Vales et al.	6770
@NP	1996	6770
@NP	Lopez-Vales et al.	6776
@NP	Lopez-Vales	6776
@NP	et al.	6788
@NP	2007	6796
@NP	axonal regrowth	6818
@NP	the lesion site and support survival	6841
@NP	rubrospinal neurons	6906
@NP	cervical spinal cord hemisection	6932
@NP	adult rats	6968
@NP	transplantation into the injured human spinal cord	6986
@NP	transplantation	6986
@NP	the injured human spinal cord	7007
@NP	large quantities of OEC	7050
@NP	large quantities	7050
@NP	OEC	7070
@NP	the time in culture	7105
@NP	the time	7105
@NP	culture	7117
@NP	we	7126
@NP	growth-promoting and neuroprotective effects	7138
@NP	short-term and long-term	7186
@NP	cells	7220
@NP	Materials and methods	7228
@NP	Materials	7228
@NP	methods	7242
@NP	Experimental animals	7250
@NP	The experiments	7271
@NP	adult -LRB- 10 -- 12 weeks , n = 96 -RRB- female Sprague -- Dawley rats	7305
@NP	adult -LRB- 10 -- 12 weeks , n = 96 -RRB- female Sprague	7305
@NP	adult	7305
@NP	10	7312
@NP	12 weeks , n = 96	7315
@NP	12 weeks	7315
@NP	n = 96	7325
@NP	n	7325
@NP	96	7327
@NP	female Sprague	7331
@NP	Dawley rats	7346
@NP	Taconic Europe A/S	7359
@NP	Denmark	7379
@NP	The animal care and experimental procedures	7389
@NP	The animal care	7389
@NP	experimental procedures	7409
@NP	accordance	7453
@NP	the European Communities Council Directive -LRB- 86 / 609/EEC -RRB-	7469
@NP	the European Communities	7469
@NP	Council Directive -LRB- 86 / 609/EEC -RRB-	7494
@NP	Council Directive	7494
@NP	86	7513
@NP	609/EEC	7517
@NP	the Northern Swedish Committee for Ethics	7552
@NP	the Northern Swedish Committee	7552
@NP	Ethics	7587
@NP	Animal Experiments	7597
@NP	All surgical procedures	7617
@NP	general anesthesia	7662
@NP	a mixture	7687
@NP	ketamine	7700
@NP	Ketalar ® , Parke-Davis ; 100 mg/kg i.v.	7710
@NP	Ketalar ®	7710
@NP	Parke-Davis ; 100 mg/kg i.v.	7720
@NP	Parke-Davis	7720
@NP	100 mg/kg i.v.	7733
@NP	xylazine	7753
@NP	Rompun ® , Bayer ; 10 mg/kg i.v.	7763
@NP	Rompun ®	7763
@NP	Bayer ; 10 mg/kg i.v.	7772
@NP	Bayer	7772
@NP	10 mg/kg i.v.	7779
@NP	Culture of olfactory ensheathing cells Primary cultures	7795
@NP	Culture of olfactory ensheathing cells	7795
@NP	Culture	7795
@NP	olfactory ensheathing cells	7806
@NP	olfactory ensheathing cells	7854
@NP	OEC	7883
@NP	technique	7929
@NP	Novikova	7940
@NP	et al. , 2006 ; Pettersson et al. , 2010 ; Ramon-Cueto and Nieto-Sampedro , 1994	7949
@NP	et al. , 2006	7949
@NP	et al.	7949
@NP	2006	7957
@NP	Pettersson et al. , 2010	7963
@NP	Pettersson	7963
@NP	et al. , 2010	7974
@NP	et al.	7974
@NP	2010	7982
@NP	Ramon-Cueto and Nieto-Sampedro , 1994	7988
@NP	Ramon-Cueto and Nieto-Sampedro	7988
@NP	1994	8020
@NP	Adult female rats -LRB- n = 25 -RRB-	8027
@NP	Adult female rats	8027
@NP	n	8046
@NP	25	8048
@NP	killedwith	8056
@NP	an overdose	8067
@NP	sodium pentobarbital	8082
@NP	240 mg	8104
@NP	kg , Apoteks-bolaget , Sweden	8111
@NP	kg	8111
@NP	Apoteks-bolaget	8115
@NP	Sweden	8132
@NP	the olfactory bulbs	8144
@NP	OB	8165
@NP	Hank 's balanced salt solution -LRB- HBSS , Invitrogen AB , Täby , Sweden -RRB-	8189
@NP	Hank 's balanced salt solution	8189
@NP	Hank 's	8189
@NP	HBSS	8220
@NP	Invitrogen AB	8226
@NP	Täby , Sweden	8241
@NP	andcleaned fromblood clots andmeninges	8255
@NP	The olfactory nerve and glomerular layers	8295
@NP	The olfactory nerve	8295
@NP	glomerular layers	8319
@NP	the microscope	8358
@NP	small pieces	8383
@NP	Ca2	8415
@NP	+ and Mg2 + - free HBSS	8418
@NP	and Mg2	8420
@NP	- free HBSS	8428
@NP	free	8429
@NP	inHBSS	8454
@NP	the tissuewas	8462
@NP	0.1 % trypsin	8494
@NP	15 min at 37 °C	8511
@NP	15 min	8511
@NP	37 °C	8521
@NP	The enzymatic activity	8528
@NP	a mixture of DMEM and Ham 's F-12 medium	8568
@NP	a mixture of DMEM and Ham 's	8568
@NP	a mixture	8568
@NP	DMEM and Ham	8581
@NP	1:1 ; Sigma-Aldrich Sweden AB	8609
@NP	1:1	8609
@NP	Sigma-Aldrich Sweden AB	8614
@NP	Stockholm , Sweden	8639
@NP	Stockholm	8639
@NP	Sweden	8650
@NP	2	8676
@NP	mMglutamine , 10 U/mlpenicillin ,	8678
@NP	mMglutamine	8678
@NP	10 U/mlpenicillin	8691
@NP	10 μg / ml streptomycin , 50 μg/ml gentamycin	8710
@NP	ml streptomycin , 50 μg/ml gentamycin	8717
@NP	ml streptomycin	8717
@NP	50 μg/ml gentamycin	8734
@NP	10 % fetal calf serum , FCS	8758
@NP	10 % fetal calf serum	8758
@NP	FCS	8780
@NP	D	8786
@NP	F-10S medium '' from Ramon-Cueto and Nieto-Sampedro , 1994	8789
@NP	F-10S medium ''	8789
@NP	Ramon-Cueto and Nieto-Sampedro	8808
@NP	1994	8840
@NP	The digestant	8847
@NP	800 rpm	8880
@NP	3 min	8892
@NP	re-suspended	8899
@NP	triturated 5	8916
@NP	7 times through a fire-polished , siliconized Pasteur pipette and 5	8929
@NP	7 times	8929
@NP	a fire-polished , siliconized Pasteur pipette and 5	8945
@NP	a fire-polished , siliconized Pasteur pipette	8945
@NP	5	8994
@NP	7 times	8996
@NP	a 21 G needle	9012
@NP	the resulting primary culture	9033
@NP	a mixture of OEC , fibroblasts , endothelial cells and astrocytes	9073
@NP	a mixture	9073
@NP	OEC , fibroblasts , endothelial cells and astrocytes	9086
@NP	OEC	9086
@NP	fibroblasts	9091
@NP	endothelial cells	9104
@NP	astrocytes	9126
@NP	purification of OECwas	9138
@NP	purification	9138
@NP	OECwas	9154
@NP	a method	9176
@NP	differential adhesion -LRB- a-OEC -RRB- -LRB- Nash et al. , 2001 -RRB-	9188
@NP	differential adhesion -LRB- a-OEC -RRB-	9188
@NP	differential adhesion	9188
@NP	a-OEC	9211
@NP	Nash	9219
@NP	et al. , 2001	9224
@NP	et al.	9224
@NP	2001	9232
@NP	immunomagneticbeads -LRB- b-OEC -RRB-	9240
@NP	immunomagneticbeads	9240
@NP	b-OEC	9261
@NP	Gudino	9269
@NP	Cabrera and Nieto-Sampedro , 1996 ; Lopez-Vales et al. , 2007	9277
@NP	Cabrera and Nieto-Sampedro	9277
@NP	1996 ; Lopez-Vales et al.	9305
@NP	1996	9305
@NP	Lopez-Vales et al.	9311
@NP	Lopez-Vales	9311
@NP	et al.	9323
@NP	2007	9331
@NP	The method of differential adhesion	9338
@NP	The method	9338
@NP	differential adhesion	9352
@NP	a very low adhesion rate of OEC	9386
@NP	a very low adhesion rate	9386
@NP	OEC	9414
@NP	the surface of uncoated culture flasks -LRB- Nash et al. , 2001 -RRB-	9421
@NP	the surface	9421
@NP	uncoated culture flasks -LRB- Nash et al. , 2001 -RRB-	9436
@NP	uncoated culture flasks	9436
@NP	Nash	9461
@NP	et al. , 2001	9466
@NP	et al.	9466
@NP	2001	9474
@NP	The cell suspension obtained from each pair of OB	9481
@NP	The cell suspension	9481
@NP	each pair of OB	9515
@NP	each pair	9515
@NP	OB	9528
@NP	D/F -10 S culture medium	9550
@NP	uncoated Lab-Tek ® one-chamber slides -LRB- Nalge Nunc International Corp -RRB-	9584
@NP	uncoated Lab-Tek ® one-chamber slides	9584
@NP	Nalge Nunc International Corp	9622
@NP	37 °C with 5 % CO2	9669
@NP	37 °C	9669
@NP	5 % CO2	9680
@NP	18 h	9694
@NP	the supernatant	9700
@NP	another uncoated Lab-Tek ® slide	9744
@NP	Lab-Tek ®	9761
@NP	additional 36	9794
@NP	48 h.	9808
@NP	The supernatants from three chamber slides	9814
@NP	The supernatants	9814
@NP	three chamber slides	9836
@NP	6 olfactory bulbs from 3 rats	9858
@NP	6 olfactory bulbs	9858
@NP	3 rats	9881
@NP	25 cm2	9919
@NP	poly-L-lysine-coated culture flask	9926
@NP	D/F -10 S culture medium	9966
@NP	the procedure	9997
@NP	most of the non-OEC cells	10012
@NP	most	10012
@NP	the non-OEC cells	10020
@NP	the uncoated chamber slides -LRB- Nash et al. , 2001 -RRB-	10050
@NP	the uncoated chamber slides	10050
@NP	Nash	10079
@NP	et al. , 2001	10084
@NP	et al.	10084
@NP	2001	10092
@NP	The culture	10099
@NP	another 48 h	10129
@NP	OEC	10151
@NP	the poly-Llysine - coated surface of culture flask	10168
@NP	the poly-Llysine	10168
@NP	coated surface of culture flask	10186
@NP	coated surface	10186
@NP	culture flask	10204
@NP	the medium	10234
@NP	the cells	10245
@NP	Ca2	10272
@NP	+ and Mg2 + - free HBSS	10275
@NP	and Mg2	10277
@NP	- free HBSS	10285
@NP	free	10286
@NP	The resulting purity of a-OEC	10297
@NP	The resulting purity	10297
@NP	a-OEC	10321
@NP	93 -- 95 %	10331
@NP	93	10331
@NP	The immonumagnetic purification of OEC	10339
@NP	The immonumagnetic purification	10339
@NP	OEC	10374
@NP	1	10395
@NP	week-old primary cultures	10398
@NP	sheep anti-rabbit Dynabeads	10430
@NP	M280 ; Dynal A.S. , Oslo , Norway	10459
@NP	M280	10459
@NP	Dynal A.S. , Oslo , Norway	10465
@NP	low-affinity NGF receptor IgG	10505
@NP	p75	10536
@NP	manufacturer 's recommendation	10646
@NP	manufacturer 's	10646
@NP	The Dynabeads	10677
@NP	p75 IgG for 24 h	10711
@NP	p75 IgG	10711
@NP	24 h	10723
@NP	4 °C -LRB- 2.5 μg of IgG for 107 of Dynabeads -RRB-	10731
@NP	4 °C	10731
@NP	2.5 μg of IgG for 107 of Dynabeads	10737
@NP	2.5 μg	10737
@NP	IgG for 107	10747
@NP	IgG	10747
@NP	107	10755
@NP	Dynabeads	10762
@NP	OEC suspension for 1 h at 4 °C -LRB- about 10 Dynabeads per target cell -RRB-	10787
@NP	OEC suspension	10787
@NP	1 h at 4 °C -LRB- about 10 Dynabeads per target cell -RRB-	10806
@NP	1 h	10806
@NP	4 °C -LRB- about 10 Dynabeads per target cell -RRB-	10813
@NP	4 °C	10813
@NP	10 Dynabeads per target cell	10825
@NP	10 Dynabeads	10825
@NP	target cell	10842
@NP	washing and re-suspension	10862
@NP	OEC	10889
@NP	25 cm2 poly-Llysine - coated culture flasks	10908
@NP	25 cm2 poly-Llysine	10908
@NP	coated culture flasks	10929
@NP	37 °C , 95 % humidity and 5 % CO2	10963
@NP	37 °C	10963
@NP	95 % humidity and 5 % CO2	10970
@NP	95 % humidity	10970
@NP	5 % CO2	10987
@NP	The resulting purity of b-OEC	10995
@NP	The resulting purity	10995
@NP	b-OEC	11019
@NP	80 %	11035
@NP	The medium	11570
@NP	every second day	11593
@NP	experiments	11627
@NP	cells	11639
@NP	culture for 20 weeks	11664
@NP	culture	11664
@NP	20 weeks	11676
@NP	Population doublings and cumulative growth rate	11686
@NP	Population doublings	11686
@NP	cumulative growth rate	11711
@NP	a-OEC cultures	11753
@NP	the formula PD = log	11781
@NP	number of cells harvested/number of cells seeded	11801
@NP	number	11801
@NP	cells harvested/number of cells	11811
@NP	cells harvested/number	11811
@NP	cells	11837
@NP	log 2	11851
@NP	log	11851
@NP	2	11855
@NP	Rubio	11884
@NP	et al. , 2008	11890
@NP	et al.	11890
@NP	2008	11898
@NP	vivo experiments	11912
@NP	the time from OB dissection to OEC transplantation	11930
@NP	the time	11930
@NP	OB dissection to OEC transplantation	11944
@NP	OB dissection	11944
@NP	OEC transplantation	11961
@NP	3 weeks -LRB- short-termcultured cells , OEC ST -RRB- or 7 weeks	11992
@NP	3 weeks -LRB- short-termcultured cells , OEC ST -RRB-	11992
@NP	short-termcultured cells , OEC ST	12001
@NP	short-termcultured cells , OEC	12001
@NP	short-termcultured cells	12001
@NP	OEC	12027
@NP	ST	12031
@NP	7 weeks	12038
@NP	long-term cultured cells , OEC LT	12047
@NP	long-term	12047
@NP	cells , OEC LT	12066
@NP	cells were expanded using growth medium D/F -10 S with forskolin and GGF2	12085
@NP	cells	12085
@NP	growth medium D/F	12111
@NP	-10 S with forskolin and GGF2	12128
@NP	-10 S	12128
@NP	forskolin and GGF2	12138
@NP	The timing	12158
@NP	our preliminary findings	12182
@NP	OEC cultured for 7 and 20 weeks	12212
@NP	OEC	12212
@NP	7 and 20 weeks	12229
@NP	the same neuroprotective and growth-promoting effects	12248
@NP	the same neuroprotective	12248
@NP	growth-promoting effects	12277
@NP	spinal cord transplantation -LRB- unpublished observation -RRB-	12308
@NP	spinal cord transplantation	12308
@NP	unpublished observation	12337
@NP	The purity of transplanted OEC	12363
@NP	The purity	12363
@NP	transplanted OEC	12377
@NP	immunostaining for p75 receptors and S100 protein -LRB- see below -RRB-	12413
@NP	immunostaining	12413
@NP	p75 receptors and S100 protein -LRB- see below -RRB-	12432
@NP	p75 receptors and S100 protein	12432
@NP	p75 receptors	12432
@NP	S100 protein	12450
@NP	OEC	12476
@NP	Lab-Tek ® 8-chambers slides	12501
@NP	a density of 15,000 cells per well	12531
@NP	a density	12531
@NP	15,000 cells per well	12544
@NP	15,000 cells	12544
@NP	2 days	12570
@NP	4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH = 7.4 -RRB-	12597
@NP	4 % paraformaldehyde	12597
@NP	0.1 M phosphate buffer -LRB- pH = 7.4 -RRB-	12620
@NP	0.1 M phosphate buffer	12620
@NP	pH	12644
@NP	7.4	12647
@NP	room temperature for 20 min	12655
@NP	room temperature	12655
@NP	20 min	12676
@NP	OEC	12696
@NP	fluorescent	12718
@NP	Fast Blue -LRB- Sigma-Aldrich Sweden AB , Stockholm , Sweden -RRB-	12734
@NP	Fast Blue	12734
@NP	Sigma-Aldrich Sweden AB	12745
@NP	Stockholm	12770
@NP	Sweden	12781
@NP	cells	12790
@NP	culture flasks	12815
@NP	Trypsin/EDTA	12835
@NP	the growth medium	12868
@NP	1 -- 3 × 106 cells/ml	12889
@NP	1	12889
@NP	3 × 106 cells/ml	12891
@NP	3 ×	12891
@NP	106 cells/ml	12893
@NP	Fast Bluewas	12907
@NP	cell suspension	12929
@NP	concentration 5 μl/ml for 15 min at 37 °C	12948
@NP	concentration 5 μl/ml	12948
@NP	15 min at 37 °C	12974
@NP	15 min	12974
@NP	37 °C	12984
@NP	labeling	12997
@NP	the cells	13007
@NP	25 cm2 poly-L-lysine-coated culture flasks	13047
@NP	25 cm2	13047
@NP	growth medium	13095
@NP	additional 72 h	13122
@NP	transplantation	13145
@NP	spinal cord -LRB- Pettersson et al. , 2010 -RRB-	13166
@NP	spinal cord	13166
@NP	Pettersson	13179
@NP	et al. , 2010	13190
@NP	et al.	13190
@NP	2010	13198
@NP	green fluorescent protein -LRB- GFP -RRB- in OEC -LRB- Fig. 1E -RRB-	13216
@NP	green fluorescent protein -LRB- GFP -RRB-	13216
@NP	green fluorescent protein	13216
@NP	GFP	13243
@NP	OEC -LRB- Fig. 1E -RRB-	13251
@NP	OEC	13251
@NP	Fig. 1E	13256
@NP	we	13266
@NP	retroviral expression system	13274
@NP	Retroviral packaging cell line PT67 -LRB- Clontech , Palo Alto , USA -RRB-	13304
@NP	Retroviral packaging cell line PT67	13304
@NP	Clontech	13341
@NP	Palo Alto	13351
@NP	USA	13362
@NP	high glucose DMEM	13385
@NP	Invitrogen AB	13404
@NP	Täby	13419
@NP	Sweden	13425
@NP	penicillin	13451
@NP	100 U	13463
@NP	ml , streptomycin	13470
@NP	ml	13470
@NP	streptomycin	13474
@NP	100 μg/ml -LRB- Invitrogen AB , Täby , Sweden -RRB- and 10 % FCS	13487
@NP	100 μg/ml -LRB- Invitrogen AB , Täby , Sweden -RRB-	13487
@NP	Invitrogen AB	13498
@NP	Täby	13513
@NP	Sweden	13519
@NP	10 % FCS	13531
@NP	a retroviral expression vector pLEGFPpuro	13560
@NP	The GFP expression vector pLEGFPpuro	13603
@NP	substitution	13654
@NP	the neomycin resistance gene	13670
@NP	the retroviral vector pLEGFP-N1 -LRB- Clontech , Palo Alto , USA -RRB-	13702
@NP	the retroviral vector pLEGFP-N1	13702
@NP	Clontech	13735
@NP	Palo Alto	13745
@NP	USA	13756
@NP	the puromycin resistance gene	13764
@NP	pMSCVpuro -LRB- Clontech , Palo Alto , USA -RRB-	13799
@NP	pMSCVpuro	13799
@NP	Clontech	13810
@NP	Palo Alto	13820
@NP	USA	13831
@NP	The transfection of PT67 cells	13837
@NP	The transfection	13837
@NP	PT67 cells	13857
@NP	a lipofection method	13880
@NP	Lipofectamin 2000	13906
@NP	Invitrogen	13925
@NP	Carlsbad	13937
@NP	USA	13947
@NP	the protocol provided by the manufacturer	13965
@NP	the protocol	13965
@NP	the manufacturer	13990
@NP	cells were selected with puromycin and maintained	14033
@NP	cells	14033
@NP	puromycin	14058
@NP	Clontech	14084
@NP	Palo Alto	14094
@NP	USA	14105
@NP	virus production	14115
@NP	the packaging cells	14133
@NP	confluence about 60 %	14168
@NP	confluence	14168
@NP	60 %	14185
@NP	37 °C	14213
@NP	a 32 °C incubator	14240
@NP	95 % humidity and 5 % CO2	14263
@NP	95 % humidity	14263
@NP	5 % CO2	14280
@NP	72 h	14294
@NP	virus containing medium	14300
@NP	virus	14300
@NP	medium	14317
@NP	0.45 μm low-protein binding filter -LRB- Pall Corporation , Cornwall , UK -RRB-	14359
@NP	0.45 μm low-protein binding filter	14359
@NP	0.45 μm	14359
@NP	low-protein binding filter	14367
@NP	Pall Corporation , Cornwall , UK	14395
@NP	Pall Corporation , Cornwall	14395
@NP	UK	14423
@NP	transduction	14432
@NP	OEC	14446
@NP	a density of 5 × 103 cells per cm2	14465
@NP	a density	14465
@NP	5 × 103 cells per cm2	14478
@NP	5 × 103 cells	14478
@NP	cm2	14494
@NP	2 days later	14502
@NP	their growth medium	14515
@NP	the viral medium	14553
@NP	8 μl/ml polybrene -LRB- Sigma-Aldrich , Milwaukee , USA -RRB-	14581
@NP	8 μl/ml polybrene	14581
@NP	Sigma-Aldrich	14600
@NP	Milwaukee	14615
@NP	USA	14626
@NP	The cells	14632
@NP	32 °C for 24 h.	14655
@NP	32 °C	14655
@NP	24 h.	14665
@NP	transduction	14677
@NP	the viral medium	14691
@NP	a fresh OEC growth medium	14723
@NP	Transduction efficacy	14750
@NP	about 40 %	14776
@NP	incubation at 37 °C for 48 h	14797
@NP	incubation	14797
@NP	37 °C for 48 h	14811
@NP	37 °C	14811
@NP	48 h	14821
@NP	the GFP-positive cells	14827
@NP	non-transduced cells	14870
@NP	fluorescence	14894
@NP	cell sorter technique -LRB- FACS DiVa , BD Biosciences , San Jose , USA -RRB-	14917
@NP	cell sorter technique	14917
@NP	FACS DiVa , BD Biosciences , San Jose , USA	14940
@NP	FACS DiVa	14940
@NP	BD Biosciences	14951
@NP	San Jose	14967
@NP	USA	14977
@NP	Spinal cord injury and transplantation	14983
@NP	Spinal cord injury	14983
@NP	transplantation	15006
@NP	cervical laminectomy	15028
@NP	the lateral funiculus	15050
@NP	adjacent gray matter of the C4 spinal cord segment	15076
@NP	adjacent gray matter	15076
@NP	the C4 spinal cord segment	15100
@NP	the left side	15146
@NP	The rats	15161
@NP	experimental groups receiving different treatments	15197
@NP	experimental groups	15197
@NP	different treatments	15227
@NP	i	15250
@NP	spinal cord injury -LRB- SCI -RRB-	15253
@NP	spinal cord injury	15253
@NP	SCI	15273
@NP	treatment -LRB- SCI , n = 17 -RRB-	15286
@NP	treatment	15286
@NP	SCI , n = 17	15297
@NP	SCI	15297
@NP	n = 17	15302
@NP	n	15302
@NP	17	15304
@NP	SCI	15314
@NP	transplantation	15330
@NP	short-term cultured a-OEC -LRB- a-OEC ST , n = 14 -RRB-	15349
@NP	short-term cultured a-OEC	15349
@NP	a-OEC ST , n = 14	15376
@NP	a-OEC ST	15376
@NP	n = 14	15386
@NP	n	15386
@NP	14	15388
@NP	SCI	15399
@NP	transplantation	15415
@NP	long-term cultured a-OEC -LRB- a-OEC LT , n = 17 -RRB-	15434
@NP	long-term cultured a-OEC	15434
@NP	a-OEC LT , n = 17	15460
@NP	a-OEC LT	15460
@NP	n = 17	15470
@NP	n	15470
@NP	17	15472
@NP	SCI	15485
@NP	transplantation of short-term cultured b-OEC -LRB- b-OEC ST , n = 13 -RRB-	15501
@NP	transplantation	15501
@NP	short-term cultured b-OEC -LRB- b-OEC ST , n = 13 -RRB-	15520
@NP	short-term cultured b-OEC	15520
@NP	b-OEC ST , n = 13	15547
@NP	b-OEC ST	15547
@NP	n = 13	15557
@NP	n	15557
@NP	13	15559
@NP	Transplantation	15564
@NP	long-term cultured b-OEC was not performed since our results in vitro	15583
@NP	long-term	15583
@NP	b-OEC	15602
@NP	our results	15632
@NP	Results , Olfactory ensheathing cell culture	15658
@NP	Results	15658
@NP	Olfactory ensheathing cell culture	15667
@NP	it	15721
@NP	80 % purity of b-OEC	15753
@NP	80 % purity	15753
@NP	b-OEC	15767
@NP	more than 2 -- 3 weeks due to contamination	15777
@NP	more than 2	15777
@NP	3 weeks	15789
@NP	contamination	15804
@NP	non-OEC cells	15823
@NP	Five rats	15838
@NP	1 week	15851
@NP	Fast Blue application	15864
@NP	the lumbar spinal cord and 5 rats	15889
@NP	the lumbar spinal cord	15889
@NP	5 rats	15916
@NP	1 week after anterograde labeling of rubrospinal axons	15926
@NP	1 week	15926
@NP	anterograde labeling of rubrospinal axons	15939
@NP	anterograde labeling	15939
@NP	rubrospinal axons	15963
@NP	dextran amine	15999
@NP	`` control '' in histograms	16014
@NP	`` control ''	16014
@NP	histograms	16027
@NP	baseline controls	16049
@NP	transplantation , the cells cultured in D/F -10 Swith	16072
@NP	transplantation	16072
@NP	the cells cultured in D/F -10 Swith	16089
@NP	the cells	16089
@NP	D/F -10 Swith	16111
@NP	2 μMforskolin and recombinant human GGF-2	16123
@NP	2 μMforskolin	16123
@NP	recombinant human GGF-2	16141
@NP	Trypsin/EDTA	16184
@NP	105 cells/μl in the growth mediumwithout serum	16225
@NP	105 cells/μl	16225
@NP	the growth mediumwithout serum	16241
@NP	transfer	16279
@NP	a siliconized glass micropipette	16293
@NP	outer diameter 100 μm	16327
@NP	outer diameter	16327
@NP	100 μm	16342
@NP	a 5 μl Hamiltone syringe	16362
@NP	1.5 -- 1.6	16388
@NP	μl of the cell suspension -LRB- 150,000 -- 160,000 cells -RRB-	16396
@NP	μl	16396
@NP	the cell suspension -LRB- 150,000 -- 160,000 cells -RRB-	16402
@NP	the cell suspension	16402
@NP	150,000 -- 160,000 cells	16423
@NP	150,000	16423
@NP	160,000 cells	16431
@NP	10 min	16458
@NP	the lateral funiculus -LRB- depths 1.0 mm -RRB-	16489
@NP	the lateral funiculus	16489
@NP	depths 1.0 mm	16512
@NP	depths	16512
@NP	1.0 mm	16519
@NP	approximately 1 mm rostral and 1 mm caudal to the lesion site	16530
@NP	approximately 1 mm rostral	16530
@NP	1 mm caudal to the lesion site	16561
@NP	1 mm caudal	16561
@NP	the lesion site	16576
@NP	Stoelting 's Lab Standard Stereotaxic Instrument -LRB- Stoelting Co. , USA -RRB-	16598
@NP	Stoelting 's Lab Standard Stereotaxic Instrument	16598
@NP	Stoelting 's	16598
@NP	Stoelting Co.	16647
@NP	USA	16662
@NP	The micropipette	16668
@NP	place for additional 2 -- 3 min	16697
@NP	place for additional 2	16697
@NP	place	16697
@NP	additional 2	16707
@NP	3 min	16720
@NP	Dura mater	16726
@NP	stretched parafilm	16754
@NP	Spongostan ® , muscles and skin	16777
@NP	Spongostan ®	16777
@NP	muscles	16790
@NP	skin	16802
@NP	layers	16822
@NP	the rats	16834
@NP	analgesic Finadyne -LRB- Schering-Plough , Denmark ; 2.5 mg/kg , i.m. -RRB-	16854
@NP	analgesic Finadyne	16854
@NP	Schering-Plough , Denmark	16874
@NP	2.5 mg/kg , i.m.	16900
@NP	2.5 mg/kg	16900
@NP	i.m.	16911
@NP	saline -LRB- 2 ml s.c. -RRB-	16918
@NP	saline	16918
@NP	2 ml s.c.	16926
@NP	benzylpenicillin	16941
@NP	Boehringer Ingelheim ; 60 mg i.m.	16959
@NP	Boehringer Ingelheim	16959
@NP	60 mg i.m.	16981
@NP	Retrograde labeling of rubrospinal neurons	16994
@NP	Retrograde labeling	16994
@NP	rubrospinal neurons	17017
@NP	the experiments	17040
@NP	neuronal survival , rubrospinal neurons	17069
@NP	neuronal survival	17069
@NP	rubrospinal neurons	17088
@NP	retrograde tracer	17126
@NP	1 week	17144
@NP	SCI -LRB- Novikova et al. , 2002 -RRB-	17158
@NP	SCI	17158
@NP	Novikova	17163
@NP	et al. , 2002	17172
@NP	et al.	17172
@NP	2002	17180
@NP	a laminectomy	17197
@NP	the L1 spinal cord segment	17212
@NP	the L1	17212
@NP	spinal cord segment	17219
@NP	the dorsal portion of the left lateral funiculus including the rubrospinal tract	17255
@NP	the dorsal portion	17255
@NP	the left lateral funiculus including the rubrospinal tract	17277
@NP	the left lateral funiculus	17277
@NP	the rubrospinal tract	17314
@NP	a fine scissors	17356
@NP	an operating microscope	17378
@NP	A small pellet	17403
@NP	1 to 2 μl	17432
@NP	a 2 % aqueous solution of the non-toxic fluorescent tracer Fast Blue	17445
@NP	a 2 % aqueous solution	17445
@NP	the non-toxic fluorescent tracer Fast Blue	17470
@NP	the non-toxic fluorescent tracer	17470
@NP	Fast Blue	17503
@NP	Sigma-Aldrich Sweden AB	17514
@NP	the lesion cavity	17555
@NP	a thin sheet of parafilm and a small piece of Spongostan ®	17590
@NP	a thin sheet of parafilm	17590
@NP	a thin sheet	17590
@NP	parafilm	17606
@NP	a small piece of Spongostan ®	17619
@NP	a small piece	17619
@NP	Spongostan ®	17636
@NP	Anterograde	17649
@NP	rubrospinal axons	17672
@NP	Anterograde labeling of rubrospinal axons	17690
@NP	Anterograde labeling	17690
@NP	rubrospinal axons	17714
@NP	us previously -LRB- Novikova et al. , 2002 -RRB-	17762
@NP	us previously	17762
@NP	us	17762
@NP	Novikova	17777
@NP	et al. , 2002	17786
@NP	et al.	17786
@NP	2002	17794
@NP	brief	17804
@NP	12 weeks after spinal cord injury	17814
@NP	12 weeks	17814
@NP	spinal cord injury	17829
@NP	the rats	17849
@NP	a stereotaxic frame	17874
@NP	a 2 mm hole	17898
@NP	the skull	17925
@NP	access	17944
@NP	the red nucleus	17954
@NP	A glass micropipette -LRB- outer tip diameter 40 -- 50 μm -RRB-	17971
@NP	A glass micropipette	17971
@NP	outer tip diameter	17993
@NP	40 -- 50 μm	18012
@NP	40	18012
@NP	50 μm	18016
@NP	a 10 % solution	18035
@NP	dextran amine in saline	18066
@NP	dextran amine	18066
@NP	saline	18083
@NP	BDA ; 10 000 MW	18091
@NP	BDA	18091
@NP	10 000 MW	18096
@NP	10 000	18096
@NP	MW	18103
@NP	lysine fixable , Molecular Probes	18107
@NP	lysine fixable	18107
@NP	Molecular Probes	18123
@NP	stereotaxic insertions	18154
@NP	the magnocellular and parvicellular regions	18182
@NP	the red nucleus	18229
@NP	6.6 and 6.1 mm caudal to the bregma	18246
@NP	6.6 and 6.1 mm caudal	18246
@NP	the bregma	18271
@NP	0.7 mm lateral to the midline	18283
@NP	0.7 mm lateral	18283
@NP	the midline	18301
@NP	7.2 mm ventral to the bregma	18318
@NP	7.2 mm	18318
@NP	the bregma	18336
@NP	Stoelting 's Lab Standard Stereotaxic Instrument -LRB- Stoelting Co. , USA -RRB-	18354
@NP	Stoelting 's Lab Standard Stereotaxic Instrument	18354
@NP	Stoelting 's	18354
@NP	Stoelting Co.	18403
@NP	USA	18418
@NP	BDA	18424
@NP	anodal current pulses of 10 μA -LRB- 7 s on/7 s off -RRB-	18470
@NP	anodal current pulses	18470
@NP	10 μA -LRB- 7 s on/7 s off -RRB-	18495
@NP	10 μA	18495
@NP	7 s on/7 s off	18502
@NP	7 s	18502
@NP	on/7 s off	18506
@NP	on/7 s	18506
@NP	the microelectrode for 10 min	18526
@NP	the microelectrode	18526
@NP	10 min	18549
@NP	The microelectrode	18557
@NP	place for additional 2 -- 3 min	18593
@NP	place for additional 2	18593
@NP	place	18593
@NP	additional 2	18603
@NP	3 min	18616
@NP	Tissue processing	18623
@NP	3	18644
@NP	8 and 13 weeks the animals	18647
@NP	8 and 13 weeks	18647
@NP	the animals	18662
@NP	an intraperitoneal overdose of sodium pentobarbital	18704
@NP	an intraperitoneal overdose	18704
@NP	sodium pentobarbital	18735
@NP	Tyrode 's solution	18789
@NP	Tyrode 's	18789
@NP	4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	18819
@NP	4 % paraformaldehyde	18819
@NP	0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	18842
@NP	0.1 M phosphate buffer	18842
@NP	pH 7.4	18866
@NP	the experiments	18878
@NP	anterograde BDA-labeling	18900
@NP	the fixation	18926
@NP	a mixture of 4 % paraformaldehyde and 0.5 % glutaraldehyde	18952
@NP	a mixture	18952
@NP	4 % paraformaldehyde and 0.5 % glutaraldehyde	18965
@NP	4 % paraformaldehyde	18965
@NP	0.5 % glutaraldehyde	18989
@NP	0.1 Mphosphate buffer -LRB- pH = 7.4 -RRB-	19012
@NP	0.1 Mphosphate buffer	19012
@NP	pH	19035
@NP	7.4	19038
@NP	Spinal cord segments C3	19044
@NP	C5 and the brain stem	19068
@NP	C5	19068
@NP	the brain stem	19075
@NP	the same fixative	19129
@NP	immunohistochemistry	19152
@NP	spinal cord segments C3 -- C5	19174
@NP	spinal cord segments C3	19174
@NP	C5	19198
@NP	1 -- 2 h , cryoprotected in 10 % and 20 % sucrose for 2 --	19221
@NP	1	19221
@NP	2 h , cryoprotected in 10 % and 20 % sucrose for 2	19223
@NP	2 h , cryoprotected in 10 %	19223
@NP	2 h	19223
@NP	10 %	19245
@NP	20 % sucrose for 2	19253
@NP	20 % sucrose	19253
@NP	2	19269
@NP	3 days	19271
@NP	liquid isopentane	19292
@NP	Serial longitudinal 16-μm-thick sections	19311
@NP	a cryomicrotome -LRB- Leica Instruments , Germany -RRB- , thaw-mounted in pairs	19364
@NP	a cryomicrotome	19364
@NP	Leica Instruments	19381
@NP	Germany	19400
@NP	pairs	19426
@NP	SuperFrost ® Plus slides	19437
@NP	SuperFrost ®	19437
@NP	slides	19453
@NP	overnight	19467
@NP	room temperature	19480
@NP	− 85 °C	19511
@NP	processing	19525
@NP	fluorescence microscopy and cell counts	19541
@NP	50-μm-thick serial transverse sections from the midbrain	19582
@NP	50-μm-thick serial transverse sections	19582
@NP	the midbrain	19626
@NP	a vibratome -LRB- Leica Instruments , Germany -RRB-	19651
@NP	a vibratome	19651
@NP	Leica Instruments	19664
@NP	Germany	19683
@NP	gelatin-coated glass slides	19704
@NP	air	19733
@NP	xylene	19764
@NP	DPX -LRB- Kebo Lab AB , Sweden -RRB-	19791
@NP	DPX	19791
@NP	Kebo Lab AB	19796
@NP	Sweden	19809
@NP	demonstration of anterogradely BDA-labeled rubrospinal axons and arborizations	19822
@NP	demonstration	19822
@NP	anterogradely BDA-labeled rubrospinal axons and arborizations	19839
@NP	anterogradely BDA-labeled rubrospinal axons	19839
@NP	arborizations	19887
@NP	serial 50-μm-thick transverse sections -LRB- C3 spinal cord segments -RRB-	19902
@NP	serial 50-μm-thick transverse sections	19902
@NP	C3 spinal cord segments	19942
@NP	C3	19942
@NP	spinal cord segments	19945
@NP	longitudinal sections -LRB- C4 -- C5 spinal cord segments -RRB-	19971
@NP	longitudinal sections	19971
@NP	C4	19994
@NP	C5 spinal cord segments	19997
@NP	C5	19997
@NP	spinal cord segments	20000
@NP	a cryomicrotome or vibratome	20034
@NP	a modified ABC method -LRB- Novikova et al. , 2002 -RRB-	20090
@NP	a modified ABC method	20090
@NP	Novikova	20113
@NP	et al. , 2002	20122
@NP	et al.	20122
@NP	2002	20130
@NP	free-floating sections	20146
@NP	PBS	20184
@NP	6 h at room temperature	20203
@NP	6 h	20203
@NP	room temperature	20210
@NP	avidin	20232
@NP	biotin	20239
@NP	peroxidase complex -LRB- 1:1:100 ; Vector Laboratories , Burlingame , CA -RRB-	20246
@NP	peroxidase complex	20246
@NP	1:1:100 ; Vector Laboratories	20266
@NP	1:1:100	20266
@NP	Vector Laboratories	20275
@NP	Burlingame , CA	20296
@NP	Burlingame	20296
@NP	CA	20308
@NP	PBS containing 0.3 % Triton X-100 and 1 % bovine serum albumin	20315
@NP	PBS	20315
@NP	0.3 % Triton X-100 and 1 % bovine serum albumin	20330
@NP	0.3 % Triton X-100	20330
@NP	1 % bovine serum albumin	20352
@NP	1 %	20352
@NP	a solution	20390
@NP	0.05 % of 3,3 ′ - diaminobenzidine tetrahydrochloride -LRB- DAB , Sigma -RRB-	20412
@NP	0.05 % of 3,3 ′	20412
@NP	0.05 %	20412
@NP	3,3	20421
@NP	diaminobenzidine tetrahydrochloride -LRB- DAB , Sigma -RRB-	20426
@NP	diaminobenzidine tetrahydrochloride	20426
@NP	DAB	20463
@NP	Sigma	20468
@NP	0.06 % NiCl2	20476
@NP	0.06 %	20476
@NP	NiCl2	20482
@NP	0.003 % H2O2	20492
@NP	0.003 %	20492
@NP	H2O2	20499
@NP	glass slides	20516
@NP	cresyl violet	20550
@NP	DPX	20584
@NP	Immunohistochemistry Immunostaining	20589
@NP	longitudinal 16-μm-thick spinal cord sections and cells	20642
@NP	Lab-Tek ® slides	20710
@NP	All primary antibodies	21376
@NP	2 h at room temperature	21416
@NP	2 h	21416
@NP	room temperature	21423
@NP	PBS , secondary goat anti-mouse and goat anti-rabbit antibodies	21458
@NP	PBS	21458
@NP	secondary goat anti-mouse	21463
@NP	goat anti-rabbit antibodies	21493
@NP	Alexa Fluor ® 488	21521
@NP	Alexa Fluor ® 568 -LRB- 1:300 ; Molecular Probes , Invitrogen -RRB-	21542
@NP	Alexa Fluor ® 568	21542
@NP	1:300	21560
@NP	Molecular Probes , Invitrogen	21567
@NP	Molecular Probes	21567
@NP	Invitrogen	21585
@NP	1 h	21614
@NP	room temperature in the dark	21621
@NP	room temperature	21621
@NP	the dark	21641
@NP	The slides	21651
@NP	Vectashield ® mounting medium -LRB- Vector Laboratories -RRB-	21685
@NP	Vectashield ® mounting medium	21685
@NP	Vector Laboratories	21715
@NP	The staining specificity	21737
@NP	omission of primary antibodies	21776
@NP	omission	21776
@NP	primary antibodies	21788
@NP	Counts	21808
@NP	Fast Blue-labeled rubrospinal neurons	21818
@NP	The nuclear profiles of the retrogradely labeled neurons	21856
@NP	The nuclear profiles	21856
@NP	the retrogradely labeled neurons	21880
@NP	the retrogradely	21880
@NP	neurons	21905
@NP	all sections	21929
@NP	the red nucleus at 250 × magnification	21950
@NP	the red nucleus	21950
@NP	250 × magnification	21969
@NP	The total number of profiles	21989
@NP	The total number	21989
@NP	profiles	22009
@NP	split nuclei	22040
@NP	the nuclear diameters	22060
@NP	comparison	22096
@NP	the section thickness used	22112
@NP	the section thickness	22112
@NP	Novikova	22140
@NP	et al. , 2000 , 2002	22149
@NP	et al.	22149
@NP	2000	22157
@NP	2002	22163
@NP	We	22170
@NP	the accuracy of this technique in estimation of retrograde cell death	22207
@NP	the accuracy	22207
@NP	this technique in estimation of retrograde cell death	22223
@NP	this technique	22223
@NP	estimation of retrograde cell death	22241
@NP	estimation	22241
@NP	retrograde cell death	22255
@NP	that	22291
@NP	physical disector method -LRB- Ma et al. , 2001 -RRB-	22310
@NP	physical disector method	22310
@NP	Ma	22336
@NP	et al. , 2001	22339
@NP	et al.	22339
@NP	2001	22347
@NP	counts	22357
@NP	neurons reconstructed from serial sections -LRB- Novikov et al. , 1997 -RRB-	22367
@NP	neurons	22367
@NP	serial sections -LRB- Novikov et al. , 1997 -RRB-	22394
@NP	serial sections	22394
@NP	Novikov	22411
@NP	et al. , 1997	22419
@NP	et al.	22419
@NP	1997	22427
@NP	Counts of rubrospinal axons and arborizations Rubrospinal sprouting	22434
@NP	Counts of rubrospinal axons and arborizations Rubrospinal	22434
@NP	Counts of rubrospinal axons and arborizations	22434
@NP	Counts	22434
@NP	rubrospinal axons and arborizations	22444
@NP	20 randomly selected transverse sections	22517
@NP	the C2 spinal cord segment of normal rats	22563
@NP	the C2 spinal cord segment	22563
@NP	normal rats	22593
@NP	13 weeks after SCI	22612
@NP	13 weeks	22612
@NP	SCI	22627
@NP	cell transplantation as described previously -LRB- Novikova et al. , 2002 -RRB-	22635
@NP	cell transplantation	22635
@NP	Novikova	22681
@NP	et al. , 2002	22690
@NP	et al.	22690
@NP	2002	22698
@NP	Rubrospinal arborizations in lamina V of the C2 spinal segment	22705
@NP	Rubrospinal arborizations	22705
@NP	lamina V of the C2 spinal segment	22734
@NP	lamina V	22734
@NP	the C2 spinal segment	22746
@NP	four nonoverlapping areas	22785
@NP	2000 final magnification with a Nikon DXM1200 digital camera	22814
@NP	2000 final magnification	22814
@NP	a Nikon DXM1200 digital camera	22844
@NP	Matrox Inspector 3.1 software	22893
@NP	Matrox Inspector	22893
@NP	3.1 software	22910
@NP	Matrox Electronic Systems Ltd. , Quebec , Canada	22924
@NP	Matrox Electronic Systems Ltd.	22924
@NP	Quebec , Canada	22956
@NP	The final image size	22973
@NP	1280 × 1024 pixels	22998
@NP	1280 ×	22998
@NP	1024 pixels	23003
@NP	the area of 54.18 × 43.35 μm	23035
@NP	the area	23035
@NP	54.18 × 43.35 μm	23047
@NP	54.18 ×	23047
@NP	43.35 μm	23054
@NP	The number	23064
@NP	labeled profiles	23078
@NP	the relative tissue area	23099
@NP	profiles	23144
@NP	each image at a constant discrimination level and an average value	23173
@NP	each image	23173
@NP	a constant discrimination level and an average value	23187
@NP	a constant discrimination level	23187
@NP	an average value	23223
@NP	each section	23259
@NP	the number	23288
@NP	rubrospinal stem axons in the lateral funiculus	23310
@NP	rubrospinal stem axons	23310
@NP	the lateral funiculus	23336
@NP	five randomly selected sections at 250 × final magnification	23361
@NP	five randomly selected sections	23361
@NP	250 × final magnification	23396
@NP	values describing the mean number of arborizations per labeled stem axon	23422
@NP	values	23422
@NP	the mean number of arborizations per labeled stem axon	23440
@NP	the mean number	23440
@NP	arborizations per labeled stem axon	23459
@NP	arborizations	23459
@NP	labeled stem axon	23477
@NP	Image processing Preparations	23512
@NP	a Nikon DXM1200 digital camera attached to a Leitz microscope	23565
@NP	a Nikon DXM1200 digital camera	23565
@NP	a Leitz microscope	23608
@NP	The captured images	23628
@NP	a single canvas	23675
@NP	Adobe Photoshop software	23709
@NP	The contrast and brightness	23735
@NP	optimal clarity	23788
@NP	Statistical analysis One-way analysis	23805
@NP	variance	23846
@NP	ANOVA	23856
@NP	a post hoc Newman -- Keuls Multiple Comparison Test	23875
@NP	a post hoc Newman	23875
@NP	Keuls Multiple Comparison Test	23893
@NP	statistical differences	23946
@NP	the experimental groups	23978
@NP	Prism ® , GraphPad Software	24003
@NP	Prism ®	24003
@NP	GraphPad Software	24011
@NP	Inc ; San Diego , CA	24030
@NP	Inc	24030
@NP	San Diego , CA	24035
@NP	San Diego	24035
@NP	CA	24046
@NP	Result Fig. 1 .	24052
@NP	Result Fig.	24052
@NP	1	24064
@NP	Primary culture of olfactory ensheathing cells , OEC -LRB- A -RRB- and OEC	24067
@NP	Primary culture	24067
@NP	olfactory ensheathing cells , OEC -LRB- A -RRB- and OEC	24086
@NP	olfactory ensheathing cells	24086
@NP	OEC -LRB- A -RRB- and OEC	24115
@NP	OEC -LRB- A -RRB-	24115
@NP	OEC	24115
@NP	A	24120
@NP	OEC	24127
@NP	a method	24145
@NP	differential adhesion -LRB- B -- E -RRB- and immunomagnetic beads -LRB- F -RRB-	24157
@NP	differential adhesion	24157
@NP	B -- E	24180
@NP	B	24180
@NP	E	24182
@NP	immunomagnetic beads	24189
@NP	F	24211
@NP	Cell	24215
@NP	low-affinity NGF receptors p75 -LRB- p75 -RRB-	24242
@NP	low-affinity NGF receptors p75	24242
@NP	p75	24274
@NP	S-100 protein -LRB- S100 -RRB-	24280
@NP	S-100 protein	24280
@NP	S100	24295
@NP	GFAP	24305
@NP	Cells	24311
@NP	-LRB- E -RRB-	24320
@NP	GFP -LRB- green -RRB- and counterstainedwith p75 antibodies -LRB- red -RRB-	24337
@NP	GFP	24337
@NP	counterstainedwith p75 antibodies	24353
@NP	red	24388
@NP	numerous round profiles of immunomagnetic beads attached to OEC in -LRB- F -RRB-	24399
@NP	numerous round profiles	24399
@NP	immunomagnetic beads attached to OEC in -LRB- F -RRB-	24426
@NP	immunomagnetic beads	24426
@NP	OEC	24459
@NP	F	24467
@NP	Blue nuclei	24471
@NP	DAPI	24500
@NP	Scale bar	24506
@NP	50 μm -LRB- A -- D -RRB- , 80 μm -LRB- E -RRB- and 160 μm -LRB- F -RRB-	24517
@NP	50 μm -LRB- A -- D -RRB-	24517
@NP	A -- D	24524
@NP	A	24524
@NP	D	24526
@NP	80 μm -LRB- E -RRB-	24530
@NP	E	24537
@NP	160 μm -LRB- F -RRB-	24544
@NP	F	24552
@NP	Fig. 2 .	24557
@NP	Fig.	24557
@NP	2	24562
@NP	Graphs	24565
@NP	the proportion	24580
@NP	cells	24598
@NP	low-affinity NGF receptors p75 -LRB- A -RRB- and S-100 protein -LRB- B -RRB-	24622
@NP	low-affinity NGF receptors p75	24622
@NP	A	24654
@NP	S-100 protein	24661
@NP	B	24676
@NP	OEC cultures	24682
@NP	a method of differential adhesion	24709
@NP	a method	24709
@NP	differential adhesion	24721
@NP	D/S -10 S medium -LRB- D/F -10 S -RRB- ,	24755
@NP	D/S -10 S medium	24755
@NP	D/F -10 S	24771
@NP	D/F	24771
@NP	-10 S	24774
@NP	forskolin and pituitary extract -LRB- Forskolin + PitExt -RRB-	24815
@NP	forskolin and pituitary extract	24815
@NP	Forskolin + PitExt	24848
@NP	Forskolin	24848
@NP	PitExt	24858
@NP	D/F -10 S medium	24871
@NP	forskolin	24904
@NP	recombinant human glial growth factor 2 -LRB- Forskolin + GGF2 -RRB-	24918
@NP	recombinant human glial growth factor	24918
@NP	2 -LRB- Forskolin + GGF2 -RRB-	24956
@NP	2	24956
@NP	Forskolin + GGF2	24959
@NP	Forskolin	24959
@NP	GGF2	24969
@NP	Error bars	24976
@NP	S.E.M.	24992
@NP	There	24999
@NP	no statistical differences	25009
@NP	OEC cultured with forskolin and GGF2 for 3 and 7 weeks -LRB- PN0 .05 -RRB-	25044
@NP	OEC	25044
@NP	forskolin and GGF2	25062
@NP	3 and 7 weeks -LRB- PN0 .05 -RRB-	25085
@NP	3 and 7 weeks	25085
@NP	PN0 .05	25100
@NP	Graph in -LRB- C -RRB-	25109
@NP	Graph in	25109
@NP	Graph	25109
@NP	C	25119
@NP	cumulative growth rate	25128
@NP	Population Doublings per week -LRB- Rubio et al. , 2008 -RRB-	25167
@NP	Population Doublings	25167
@NP	week -LRB- Rubio et al. , 2008 -RRB-	25192
@NP	week	25192
@NP	Rubio	25198
@NP	et al. , 2008	25204
@NP	et al.	25204
@NP	2008	25212
@NP	Fig. 3 .	25220
@NP	Fig.	25220
@NP	3	25225
@NP	Horizontal spinal cord sections	25228
@NP	low-affinity NGF receptors	25278
@NP	p75 -LRB- A -- F ; p75 , red -RRB-	25305
@NP	p75	25305
@NP	A	25310
@NP	F ; p75	25312
@NP	F	25312
@NP	p75	25315
@NP	GFP-labeled OEC	25333
@NP	D , green -RRB- and Fast Blue-labeled OEC -LRB- E -- F , blue -RRB-	25352
@NP	D , green -RRB-	25352
@NP	D	25352
@NP	Fast Blue-labeled OEC -LRB- E -- F , blue -RRB-	25366
@NP	Fast Blue-labeled OEC	25366
@NP	E	25389
@NP	F , blue	25391
@NP	F	25391
@NP	blue	25394
@NP	3weeks -LRB- A -RRB-	25403
@NP	3weeks	25403
@NP	A	25410
@NP	B -- F	25422
@NP	B	25422
@NP	F	25424
@NP	transplantation	25433
@NP	Images in -LRB- C -- D -RRB- and -LRB- F -RRB-	25450
@NP	Images in -LRB- C -- D -RRB-	25450
@NP	Images	25450
@NP	C -- D	25460
@NP	C	25460
@NP	D	25462
@NP	-LRB- F -RRB-	25469
@NP	enlarged views	25477
@NP	the boxed areas in -LRB- B -RRB- and -LRB- E -RRB- , respectively	25495
@NP	the	25495
@NP	areas	25505
@NP	-LRB- B -RRB- and -LRB- E -RRB-	25513
@NP	-LRB- B -RRB-	25513
@NP	-LRB- E -RRB-	25521
@NP	Injection sites -LRB- G -- I -RRB-	25540
@NP	Injection sites	25540
@NP	G -- I	25557
@NP	G	25557
@NP	I	25559
@NP	p75 receptors	25579
@NP	8 weeks	25596
@NP	transplantation	25610
@NP	b-OEC ST -LRB- G -RRB- , a-OEC ST -LRB- H -RRB- and a-OEC LT -LRB- I -RRB-	25629
@NP	b-OEC ST -LRB- G -RRB-	25629
@NP	b-OEC ST	25629
@NP	G	25639
@NP	a-OEC ST -LRB- H -RRB-	25643
@NP	a-OEC ST	25643
@NP	H	25653
@NP	a-OEC LT -LRB- I -RRB-	25660
@NP	a-OEC LT	25660
@NP	I	25670
@NP	significant reduction of p75-immunoreactivity	25679
@NP	significant reduction	25679
@NP	p75-immunoreactivity	25704
@NP	I	25729
@NP	Arrows	25733
@NP	injection sites	25749
@NP	Asterisks	25766
@NP	trauma zones	25785
@NP	FB in -LRB- I -RRB-	25799
@NP	FB in	25799
@NP	FB	25799
@NP	I	25806
@NP	Fast Blue labeling	25819
@NP	Blue nuclei in -LRB- G -RRB- and -LRB- H -RRB-	25839
@NP	Blue nuclei	25839
@NP	-LRB- G -RRB- and -LRB- H -RRB-	25854
@NP	-LRB- G -RRB-	25854
@NP	-LRB- H -RRB-	25862
@NP	DAPI	25879
@NP	200 μm	25896
@NP	A , B , E	25907
@NP	50 μm	25917
@NP	G -- H	25927
@NP	G	25927
@NP	H	25929
@NP	25 μm	25936
@NP	I	25946
@NP	Fig. 4 .	25951
@NP	Fig.	25951
@NP	4	25956
@NP	Histogram	25959
@NP	survival of Fast Blue-labeled rubrospinal neurons at 8 weeks	25977
@NP	survival	25977
@NP	Fast Blue-labeled rubrospinal neurons at 8 weeks	25989
@NP	Fast Blue-labeled rubrospinal neurons	25989
@NP	8 weeks	26030
@NP	cervical spinal cord injury -LRB- A -RRB-	26044
@NP	cervical spinal cord injury	26044
@NP	A	26073
@NP	the density	26080
@NP	BDA-labeled rubrospinal stem axons	26095
@NP	the dorsolateral funiculus	26133
@NP	B	26161
@NP	the density	26165
@NP	rubrospinal terminal arborizations in the gray matter -LRB- C -RRB-	26180
@NP	rubrospinal terminal arborizations	26180
@NP	the gray matter -LRB- C -RRB-	26218
@NP	the gray matter	26218
@NP	C	26235
@NP	the ratio between the density of rubrospinal arborizations	26242
@NP	the ratio	26242
@NP	the density of rubrospinal arborizations	26260
@NP	the density	26260
@NP	rubrospinal arborizations	26275
@NP	the axons in the dorsolateral funiculus -LRB- D -RRB-	26305
@NP	the axons	26305
@NP	the dorsolateral funiculus -LRB- D -RRB-	26318
@NP	the dorsolateral funiculus	26318
@NP	D	26346
@NP	13 weeks after cervical spinal cord injury -LRB- SCI -RRB-	26352
@NP	13 weeks	26352
@NP	cervical spinal cord injury -LRB- SCI -RRB-	26367
@NP	cervical spinal cord injury	26367
@NP	SCI	26396
@NP	following transplantation of OEC	26405
@NP	following transplantation	26405
@NP	OEC	26434
@NP	Control	26439
@NP	untreated rats	26457
@NP	1 week after Fast Bluelabeling -LRB- A -RRB-	26475
@NP	1 week	26475
@NP	Fast Bluelabeling -LRB- A -RRB-	26488
@NP	Fast Bluelabeling	26488
@NP	A	26507
@NP	normal uninjured rats at 1 week after BDA-labeling -LRB- B -- D -RRB-	26513
@NP	normal uninjured rats	26513
@NP	1 week after BDA-labeling -LRB- B -- D -RRB-	26538
@NP	1 week	26538
@NP	BDA-labeling -LRB- B -- D -RRB-	26551
@NP	BDA-labeling	26551
@NP	B -- D	26565
@NP	B	26565
@NP	D	26567
@NP	Error bars	26571
@NP	S.E.M.	26587
@NP	-LRB- A -RRB-	26597
@NP	Pb0 .05 is indicated by * -LRB- control vs. b-OEC ST ; a-OEC ST vs.	26602
@NP	Pb0 .05	26602
@NP	* -LRB- control vs. b-OEC ST ; a-OEC ST vs.	26625
@NP	* -LRB- control vs. b-OEC ST	26625
@NP	*	26625
@NP	control vs. b-OEC ST	26628
@NP	control	26628
@NP	b-OEC ST	26640
@NP	a-OEC ST vs.	26650
@NP	SCI and b-OEC ST -RRB-	26663
@NP	SCI	26663
@NP	b-OEC	26671
@NP	ST	26677
@NP	.001	26688
@NP	# -LRB- control	26709
@NP	vs.	26720
@NP	SCI , a-OEC ST and a-OEC LT ; b-OEC ST vs.	26724
@NP	SCI , a-OEC	26724
@NP	ST and a-OEC LT ; b-OEC ST vs.	26735
@NP	ST and a-OEC LT	26735
@NP	b-OEC ST vs.	26752
@NP	SCI and a-OEC LT ; a-OEC ST vs. a-OEC LT -RRB-	26765
@NP	SCI and a-OEC	26765
@NP	LT ; a-OEC ST vs. a-OEC LT -RRB-	26779
@NP	LT	26779
@NP	a-OEC ST vs. a-OEC LT	26783
@NP	a-OEC ST	26783
@NP	a-OEC LT	26796
@NP	-LRB- B -RRB- : Pb0 .05 is indicated by * -LRB- b-OEC ST vs.	26810
@NP	-LRB- B -RRB-	26810
@NP	Pb0 .05 is indicated by * -LRB- b-OEC ST vs.	26815
@NP	Pb0 .05	26815
@NP	* -LRB- b-OEC ST vs.	26838
@NP	* -LRB- b-OEC ST	26838
@NP	*	26838
@NP	b-OEC ST	26841
@NP	b-OEC	26841
@NP	ST	26847
@NP	SCI -RRB- and Pb0 .001	26854
@NP	SCI -RRB-	26854
@NP	Pb0 .001	26863
@NP	# -LRB- control and a-OEC ST vs.	26887
@NP	# -LRB- control	26887
@NP	a-OEC ST vs.	26902
@NP	SCI , b-OEC ST and a-OEC LT -RRB- .	26915
@NP	SCI	26915
@NP	b-OEC ST and a-OEC LT -RRB-	26920
@NP	b-OEC	26920
@NP	ST and a-OEC LT -RRB-	26926
@NP	ST	26926
@NP	a-OEC LT	26933
@NP	C	26948
@NP	Pb0 .05	26952
@NP	* -LRB- b-OEC ST vs. control , SCI and a-OEC LT -RRB-	26975
@NP	*	26975
@NP	b-OEC ST vs. control , SCI and a-OEC LT	26978
@NP	b-OEC ST	26978
@NP	control , SCI and a-OEC LT	26991
@NP	control	26991
@NP	SCI	27000
@NP	a-OEC LT	27008
@NP	Pb0 .001	27022
@NP	# -LRB- a-OEC ST vs. control , SCI , b-OEC-ST and a-OEC LT -RRB-	27046
@NP	#	27046
@NP	a-OEC ST vs. control , SCI , b-OEC-ST and a-OEC LT	27049
@NP	a-OEC ST	27049
@NP	control , SCI , b-OEC-ST and a-OEC LT	27062
@NP	control	27062
@NP	SCI	27071
@NP	b-OEC-ST	27076
@NP	a-OEC LT	27089
@NP	-LRB- D -RRB- : Pb0 .05 is indicated by * -LRB- a-OEC ST vs.	27103
@NP	-LRB- D -RRB-	27103
@NP	Pb0 .05 is indicated by * -LRB- a-OEC ST vs.	27108
@NP	Pb0 .05	27108
@NP	* -LRB- a-OEC ST vs.	27131
@NP	* -LRB- a-OEC ST	27131
@NP	*	27131
@NP	a-OEC ST	27134
@NP	a-OEC	27134
@NP	ST	27140
@NP	SCI and a-OEC LT -RRB- and Pb0 .001	27147
@NP	SCI and a-OEC LT -RRB-	27147
@NP	SCI	27147
@NP	a-OEC LT	27155
@NP	Pb0 .001	27169
@NP	# -LRB- control vs. experiment ; b-OEC ST vs.	27193
@NP	# -LRB- control vs. experiment	27193
@NP	# -LRB- control	27193
@NP	experiment	27208
@NP	b-OEC ST vs.	27220
@NP	SCI , a-OEC ST and a-OEC LT -RRB- .	27233
@NP	SCI	27233
@NP	a-OEC ST and a-OEC LT -RRB-	27238
@NP	a-OEC	27238
@NP	ST and a-OEC LT -RRB-	27244
@NP	ST	27244
@NP	a-OEC LT	27251
@NP	Fig. 5 .	27263
@NP	Fig.	27263
@NP	5	27268
@NP	Horizontal spinal cord sections	27271
@NP	pan-neurofilament	27321
@NP	regeneration in the trauma zone -LRB- asterisks -RRB-	27351
@NP	regeneration	27351
@NP	the trauma zone -LRB- asterisks -RRB-	27367
@NP	the trauma zone	27367
@NP	asterisks	27384
@NP	13 weeks after cervical SCI	27398
@NP	13 weeks	27398
@NP	cervical SCI	27413
@NP	following transplantation	27430
@NP	b-OEC ST -LRB- A -RRB- , a-OEC LT -LRB- B -RRB- and a-OEC ST -LRB- E and F -RRB-	27459
@NP	b-OEC ST -LRB- A -RRB-	27459
@NP	b-OEC ST	27459
@NP	A	27469
@NP	a-OEC LT -LRB- B -RRB-	27473
@NP	a-OEC LT	27473
@NP	B	27483
@NP	a-OEC ST -LRB- E and F -RRB-	27490
@NP	a-OEC ST	27490
@NP	E and F	27500
@NP	E	27500
@NP	F	27506
@NP	areas in -LRB- A -RRB- , -LRB- B -RRB-	27516
@NP	areas	27516
@NP	-LRB- A -RRB- , -LRB- B -RRB-	27525
@NP	-LRB- A -RRB-	27525
@NP	B	27531
@NP	-LRB- E -RRB- and -LRB- F -RRB-	27535
@NP	-LRB- E -RRB-	27535
@NP	-LRB- F -RRB-	27543
@NP	-LRB- C -RRB- , -LRB- D -RRB- , -LRB- G -RRB- and -LRB- H -RRB-	27563
@NP	-LRB- C -RRB-	27563
@NP	-LRB- D -RRB-	27568
@NP	-LRB- G -RRB-	27573
@NP	-LRB- H -RRB-	27581
@NP	numerous regenerating fibers	27605
@NP	E -- F	27638
@NP	E	27638
@NP	F	27640
@NP	a-OEC ST transplantation	27649
@NP	Scale bar , 200 μm .	27675
@NP	Scale bar	27675
@NP	200 μm	27686
@NP	Fig. 6 .	27695
@NP	Fig.	27695
@NP	6	27700
@NP	Horizontal spinal cord sections	27703
@NP	A -- C	27774
@NP	A	27774
@NP	C	27776
@NP	D	27806
@NP	serotonin -LRB- E -- I -RRB-	27850
@NP	serotonin	27850
@NP	E -- I	27861
@NP	E	27861
@NP	I	27863
@NP	13 weeks	27869
@NP	cervical SCI	27884
@NP	transplantation of a-OEC ST.	27911
@NP	transplantation	27911
@NP	a-OEC ST.	27930
@NP	areas in -LRB- A -RRB- and -LRB- E -RRB-	27946
@NP	areas	27946
@NP	-LRB- A -RRB- and -LRB- E -RRB-	27955
@NP	-LRB- A -RRB-	27955
@NP	-LRB- E -RRB-	27963
@NP	enlarged in -LRB- B -- C -RRB- and -LRB- F -- I -RRB-	27971
@NP	enlarged in -LRB- B -- C -RRB- and	27971
@NP	B -- C	27984
@NP	B	27984
@NP	C	27986
@NP	F -- I	27994
@NP	F	27994
@NP	I	27996
@NP	rubrospinal and raphaespinal axons	28027
@NP	the lesion site	28071
@NP	Asterisks	28088
@NP	trauma zones	28107
@NP	Images in -LRB- A -- C -RRB-	28121
@NP	Images in	28121
@NP	Images	28121
@NP	A -- C	28132
@NP	A	28132
@NP	C	28134
@NP	cresyl violet	28161
@NP	Scale bar , 200 μm .	28176
@NP	Scale bar	28176
@NP	200 μm	28187
@NP	Olfactory ensheathing cell culture	28196
@NP	Primary OEC cultures in the present study	28231
@NP	Primary OEC cultures	28231
@NP	the present study	28255
@NP	35	28289
@NP	40 %	28292
@NP	cells immunopositive for low-affinity NGF receptor p75 -LRB- Fig. 1A -RRB-	28299
@NP	cells immunopositive for low-affinity NGF receptor p75	28299
@NP	cells	28299
@NP	low-affinity NGF receptor p75	28324
@NP	Fig. 1A	28355
@NP	purification with the method of differential adhesion	28371
@NP	purification	28371
@NP	the method of differential adhesion	28389
@NP	the method	28389
@NP	differential adhesion	28403
@NP	93 -- 95 % of cells in cultures	28426
@NP	93 -- 95 %	28426
@NP	93	28426
@NP	cells in cultures	28436
@NP	cells	28436
@NP	cultures	28445
@NP	p75 receptors , S-100 protein and GFAP -LRB- Fig. 1B , C , D -RRB-	28477
@NP	p75 receptors	28477
@NP	S-100 protein and GFAP -LRB- Fig. 1B , C , D -RRB-	28492
@NP	S-100 protein and GFAP	28492
@NP	Fig. 1B	28516
@NP	C	28524
@NP	D	28526
@NP	The majority of non-OEC cells	28530
@NP	The majority	28530
@NP	non-OEC cells	28546
@NP	Thy 1.1 - positive cells	28565
@NP	Thy 1.1	28565
@NP	positive cells	28574
@NP	pure long-term cultures of a-OEC	28618
@NP	pure long-term cultures	28618
@NP	a-OEC	28645
@NP	intraspinal transplantation	28655
@NP	we	28684
@NP	well known protocols	28696
@NP	growth medium D/F	28723
@NP	-10 S	28740
@NP	DMEM-10S	28759
@NP	forskolin and pituitary extract	28786
@NP	forskolin	28786
@NP	pituitary extract	28800
@NP	D/F -10 S medium	28824
@NP	cultures	28839
@NP	non-OEC cells	28873
@NP	1 week -LRB- Fig. 2 -RRB- and the proportion of p75-positive and S-100	28901
@NP	1 week -LRB- Fig. 2 -RRB-	28901
@NP	1 week	28901
@NP	Fig. 2	28909
@NP	the proportion of p75-positive and S-100	28921
@NP	the proportion	28921
@NP	p75-positive and S-100	28939
@NP	p75-positive	28939
@NP	S-100	28956
@NP	positive cells	28963
@NP	42 % -LRB- Pb0 .001 -RRB- and 35 % -LRB- Pb0 .001 -RRB-	28993
@NP	42 %	28993
@NP	Pb0 .001	28998
@NP	35 %	29011
@NP	Pb0 .001	29016
@NP	DMEM-10S medium supplemented with forskolin and pituitary extract	29045
@NP	DMEM-10S medium	29045
@NP	forskolin and pituitary extract	29079
@NP	forskolin	29079
@NP	pituitary extract	29093
@NP	the proportion of p75 - and S-100-positive cells	29111
@NP	the proportion	29111
@NP	p75 - and S-100-positive cells	29129
@NP	80 -- 90 % during the first week	29175
@NP	80	29175
@NP	90 % during the first week	29178
@NP	90 %	29178
@NP	the first week	29189
@NP	purification	29210
@NP	2 weeks in culture	29234
@NP	2 weeks	29234
@NP	culture	29245
@NP	it	29253
@NP	15 -- 18 % -LRB- Pb0 .0001 ; Fig. 2 -RRB-	29279
@NP	15 -- 18 %	29279
@NP	15	29279
@NP	Pb0 .0001 ; Fig. 2	29287
@NP	Pb0 .0001	29287
@NP	Fig. 2	29297
@NP	D/F -10 S medium supplemented with forskolin and recombinant human GGF2	29320
@NP	D/F -10 S medium	29320
@NP	forskolin and recombinant human GGF2	29353
@NP	forskolin	29353
@NP	recombinant human GGF2	29367
@NP	90 -- 95 % pure a-OEC for at least 11 weeks -LRB- Fig. 2 -RRB-	29401
@NP	90	29401
@NP	95 % pure a-OEC for at least 11 weeks -LRB- Fig. 2 -RRB-	29404
@NP	95 % pure a-OEC	29404
@NP	at least 11 weeks -LRB- Fig. 2 -RRB-	29423
@NP	at least 11 weeks	29423
@NP	Fig. 2	29442
@NP	Purification of primary cultures with immunomagnetic beads	29451
@NP	Purification	29451
@NP	primary cultures with immunomagnetic beads	29467
@NP	primary cultures	29467
@NP	immunomagnetic beads	29489
@NP	most cases	29522
@NP	80 % OEC purity	29536
@NP	purification	29570
@NP	numerous Dynabeads	29584
@NP	the cell surface -LRB- Fig. 1F -RRB-	29624
@NP	the cell surface	29624
@NP	Fig. 1F	29642
@NP	The number of attached Dynabeads	29652
@NP	The number	29652
@NP	attached Dynabeads	29666
@NP	2 weeks in culture	29703
@NP	2 weeks	29703
@NP	culture	29714
@NP	they	29726
@NP	spinal cord sections	29753
@NP	13 weeks	29774
@NP	transplantation -LRB- data not shown -RRB-	29789
@NP	transplantation	29789
@NP	data not shown	29806
@NP	data	29806
@NP	contrast to a-OEC	29826
@NP	contrast	29826
@NP	a-OEC	29838
@NP	we	29845
@NP	all growth mediums tested	29864
@NP	all growth mediums	29864
@NP	it	29891
@NP	80 % pure b-OEC cultures	29923
@NP	3 weeks	29963
@NP	contamination with Thy 1.1-positive and p75	29978
@NP	contamination	29978
@NP	Thy 1.1-positive and p75	29997
@NP	Thy 1.1-positive	29997
@NP	p75	30018
@NP	Distribution of olfactory ensheathing cells Three weeks	30052
@NP	Distribution	30052
@NP	olfactory ensheathing cells	30068
@NP	Three weeks	30096
@NP	transplantation	30114
@NP	numerous GFP-labeled OEC -LRB- Fig. 1E -RRB-	30131
@NP	numerous GFP-labeled OEC	30131
@NP	Fig. 1E	30157
@NP	the injection sites rostral and caudal	30182
@NP	the injection sites	30182
@NP	the spinal cord hemisection	30224
@NP	the trauma zone -LRB- Fig. 3A -RRB-	30259
@NP	the trauma zone	30259
@NP	Fig. 3A	30276
@NP	The trauma zone	30286
@NP	injection sites	30326
@NP	narrow tract formed by transplanted OEC	30345
@NP	narrow tract	30345
@NP	transplanted OEC	30368
@NP	we	30395
@NP	any OEC migration rostral and caudal	30411
@NP	any OEC migration rostral	30411
@NP	caudal	30441
@NP	the injection sites	30453
@NP	The number of GFP-OEC	30474
@NP	The number	30474
@NP	GFP-OEC	30488
@NP	8 weeks post-operatively -LRB- Fig. 3A and B -RRB-	30520
@NP	8 weeks post-operatively	30520
@NP	8 weeks	30520
@NP	Fig. 3A and B	30546
@NP	Fig. 3A	30546
@NP	B	30558
@NP	The changes	30562
@NP	the trauma zone	30595
@NP	only single GFP-positive cells	30617
@NP	Fig. 3C and D	30675
@NP	Fig. 3C	30675
@NP	D	30687
@NP	the reduction in GFP-OEC number	30697
@NP	the reduction	30697
@NP	GFP-OEC number	30714
@NP	down regulation of GFP expression -LRB- Vroemen et al. , 2005 -RRB-	30745
@NP	down regulation	30745
@NP	GFP expression -LRB- Vroemen et al. , 2005 -RRB-	30764
@NP	GFP expression	30764
@NP	Vroemen	30780
@NP	et al. , 2005	30788
@NP	et al.	30788
@NP	2005	30796
@NP	we	30803
@NP	Fast Blue-labeled OEC -LRB- Pettersson et al. , 2010 -RRB-	30824
@NP	Fast Blue-labeled OEC	30824
@NP	Pettersson	30847
@NP	et al. , 2010	30858
@NP	et al.	30858
@NP	2010	30866
@NP	distribution of these cells at 8 weeks after SCI	30887
@NP	distribution	30887
@NP	these cells at 8 weeks after SCI	30903
@NP	these cells	30903
@NP	8 weeks after SCI	30918
@NP	8 weeks	30918
@NP	SCI	30932
@NP	GFP-OEC -LRB- Fig. 3B and E -RRB-	30951
@NP	GFP-OEC	30951
@NP	Fig. 3B and E	30960
@NP	Fig. 3B	30960
@NP	E	30972
@NP	a predominant concentration of labeled cells at the injection sites	30980
@NP	a predominant concentration	30980
@NP	labeled cells at the injection sites	31011
@NP	labeled cells	31011
@NP	the injection sites	31028
@NP	Fig. 3F	31049
@NP	Immunostaining with p75	31059
@NP	Immunostaining	31059
@NP	p75	31079
@NP	p75 - immunoreactivity	31106
@NP	p75	31106
@NP	immunoreactivity	31111
@NP	labeled cells in the transplantation sites	31143
@NP	labeled cells	31143
@NP	the transplantation sites	31160
@NP	the trauma zone	31193
@NP	it	31209
@NP	the areas occupied by GFPand Fast Blue-positive OEC -LRB- Fig. 3A , B , E -RRB-	31223
@NP	the areas	31223
@NP	GFPand Fast Blue-positive OEC -LRB- Fig. 3A , B , E -RRB-	31245
@NP	GFPand Fast Blue-positive OEC	31245
@NP	Fig. 3A	31276
@NP	B	31284
@NP	E	31286
@NP	addition	31293
@NP	animals transplanted with short-term cultured OEC -LRB- OEC ST -RRB-	31303
@NP	animals	31303
@NP	short-term cultured OEC	31329
@NP	short-term	31329
@NP	OEC	31349
@NP	OEC	31354
@NP	larger areas of p75-immunostaining	31366
@NP	larger areas	31366
@NP	p75-immunostaining	31382
@NP	the injection sites -LRB- Fig. 3G , H -RRB-	31404
@NP	the injection sites	31404
@NP	Fig. 3G , H	31425
@NP	Fig. 3G	31425
@NP	H	31433
@NP	animals with long-term cultured OEC	31441
@NP	animals	31441
@NP	long-term cultured OEC	31454
@NP	long-term	31454
@NP	OEC	31473
@NP	OEC LT ; Fig. 3I	31478
@NP	OEC LT	31478
@NP	Fig. 3I	31486
@NP	Survival of rubrospinal neurons	31496
@NP	Survival	31496
@NP	rubrospinal neurons	31508
@NP	the control animals 1 week	31531
@NP	the control animals	31531
@NP	1 week	31551
@NP	Fast Blue application to the lumbar spinal cord	31564
@NP	Fast Blue application	31564
@NP	the lumbar spinal cord	31589
@NP	the red nucleus	31613
@NP	1704 ± 58 labeled neuronal profiles with nucleus -LRB- mean ± S.E.M. -RRB-	31639
@NP	1704 ± 58	31639
@NP	neuronal profiles	31655
@NP	nucleus	31678
@NP	mean ± S.E.M.	31687
@NP	mean ±	31687
@NP	S.E.M.	31692
@NP	Most of the labeled neurons	31701
@NP	Most	31701
@NP	the labeled neurons	31709
@NP	the ventral portion	31745
@NP	the magnocellular and parvicellular regions of the red nucleus	31768
@NP	the magnocellular and parvicellular regions	31768
@NP	the red nucleus	31815
@NP	8 weeks after cervical C4 SCI	31835
@NP	8 weeks	31835
@NP	cervical C4 SCI	31849
@NP	only 54 % of labeled rubrospinal neurons	31865
@NP	only 54 %	31865
@NP	labeled rubrospinal neurons	31877
@NP	the nucleus -LRB- Pb0 .001 ; Fig. 4A -RRB-	31917
@NP	the nucleus	31917
@NP	Pb0 .001 ; Fig. 4A	31930
@NP	Pb0 .001	31930
@NP	Fig. 4A	31939
@NP	most of them	31952
@NP	most	31952
@NP	them	31960
@NP	significant cell atrophy -LRB- data not shown -RRB-	31975
@NP	significant cell atrophy	31975
@NP	data not shown	32001
@NP	data	32001
@NP	Transplantation of b-OEC ST increased survival rate	32018
@NP	b-OEC	32037
@NP	84 % -LRB- Pb0 .001 ; b-OEC ST vs.	32073
@NP	84 % -LRB- Pb0 .001	32073
@NP	84 %	32073
@NP	Pb0 .001	32078
@NP	Pb0	32078
@NP	.001	32081
@NP	b-OEC ST vs.	32087
@NP	SCI ; Fig. 4A -RRB-	32100
@NP	SCI	32100
@NP	Fig. 4A	32105
@NP	Fig.	32105
@NP	4A	32110
@NP	transplantation of a-OEC ST	32122
@NP	transplantation	32122
@NP	a-OEC ST	32141
@NP	69 % of the rubrospinal neurons -LRB- Pb0 .05 ;	32160
@NP	69 %	32160
@NP	the rubrospinal neurons -LRB- Pb0 .05 ;	32167
@NP	the rubrospinal neurons	32167
@NP	Pb0 .05	32192
@NP	a-OEC ST vs.	32200
@NP	SCI ; Fig. 4A -RRB- .	32213
@NP	SCI	32213
@NP	Fig. 4A	32218
@NP	contrast	32231
@NP	transplantation of a-OEC LT	32241
@NP	transplantation	32241
@NP	a-OEC LT	32260
@NP	no effect on retrograde cell death	32273
@NP	no effect	32273
@NP	retrograde cell death	32286
@NP	SCI -LRB- Fig. 4A -RRB-	32314
@NP	SCI	32314
@NP	Fig. 4A	32319
@NP	Axonal	32329
@NP	regeneration Quantification of BDA-labeled axonal profiles	32350
@NP	regeneration Quantification	32350
@NP	BDA-labeled axonal profiles	32381
@NP	the C2	32412
@NP	cervical dorsolateral funiculus at 13 weeks after SCI	32419
@NP	cervical dorsolateral funiculus	32419
@NP	13 weeks after SCI	32454
@NP	13 weeks	32454
@NP	SCI	32469
@NP	the density of rubrospinal axons	32487
@NP	the density	32487
@NP	rubrospinal axons	32502
@NP	30 % of normal control	32549
@NP	30 %	32549
@NP	normal control	32556
@NP	Pb0 .001 ; Fig. 4B	32572
@NP	Pb0 .001	32572
@NP	Fig. 4B	32581
@NP	comparison with SCI	32594
@NP	comparison	32594
@NP	SCI	32610
@NP	transplantation of a-OEC LT	32615
@NP	transplantation	32615
@NP	a-OEC LT	32634
@NP	no effects -LRB- PN0 .05 ; Fig. 4B -- D -RRB-	32647
@NP	no effects	32647
@NP	PN0 .05	32659
@NP	Fig. 4B -- D	32667
@NP	Fig. 4B	32667
@NP	D	32675
@NP	contrast	32682
@NP	transplantation b-OEC ST	32692
@NP	transplantation b-OEC	32692
@NP	moderate increase of the density of rubrospinal stem axons	32725
@NP	moderate increase	32725
@NP	the density of rubrospinal stem axons	32746
@NP	the density	32746
@NP	rubrospinal stem axons	32761
@NP	the dorsolateral funiculus -LRB- Pb0 .05 ; Fig. 4B -RRB-	32791
@NP	the dorsolateral funiculus	32791
@NP	Pb0 .05 ; Fig. 4B	32819
@NP	Pb0 .05	32819
@NP	Fig. 4B	32827
@NP	the same time	32844
@NP	the density	32867
@NP	terminal arborizations in the gray matter -LRB- Pb0 .05 ; Fig. 4C -RRB-	32882
@NP	terminal arborizations	32882
@NP	the gray matter -LRB- Pb0 .05 ; Fig. 4C -RRB-	32908
@NP	the gray matter	32908
@NP	Pb0 .05 ; Fig. 4C	32925
@NP	Pb0 .05	32925
@NP	Fig. 4C	32933
@NP	Transplantation of a-OEC ST	32943
@NP	Transplantation	32943
@NP	a-OEC ST	32962
@NP	the density of rubrospinal stemaxons	32980
@NP	the density	32980
@NP	rubrospinal stemaxons	32995
@NP	84 % of control values -LRB- Pb0 .001 ; Fig. 4B -RRB-	33020
@NP	84 %	33020
@NP	control values -LRB- Pb0 .001 ; Fig. 4B -RRB-	33027
@NP	control values	33027
@NP	Pb0 .001 ; Fig. 4B	33043
@NP	Pb0 .001	33043
@NP	Fig. 4B	33052
@NP	156 %	33078
@NP	the density of rubrospinal terminations	33083
@NP	the density	33083
@NP	rubrospinal terminations	33098
@NP	lamina V -LRB- Pb0 .001 ; a-OEC ST vs. control ; Fig. 4C -RRB-	33126
@NP	lamina V	33126
@NP	Pb0 .001 ; a-OEC ST vs. control ; Fig. 4C	33136
@NP	Pb0 .001	33136
@NP	a-OEC ST vs. control ; Fig. 4C	33145
@NP	a-OEC ST vs. control	33145
@NP	a-OEC ST	33145
@NP	control	33158
@NP	Fig. 4C	33167
@NP	Fig.	33167
@NP	4C	33172
@NP	the number	33201
@NP	arborizations in the gray matter	33223
@NP	arborizations	33223
@NP	the gray matter	33240
@NP	the number of labeled rubrospinal axons in the dorsolateral funiculus	33259
@NP	the number	33259
@NP	rubrospinal axons in the dorsolateral funiculus	33281
@NP	rubrospinal axons	33281
@NP	the dorsolateral funiculus	33302
@NP	a significant decrease in the number of arborizations per stem axon	33330
@NP	a significant decrease	33330
@NP	the number of arborizations per stem axon	33356
@NP	the number	33356
@NP	arborizations per stem axon	33370
@NP	arborizations	33370
@NP	stem axon	33388
@NP	transplantation of both b-OEC ST -LRB- Pb0 .001 ; Fig. 4D -RRB- and a-OEC ST	33414
@NP	transplantation	33414
@NP	both b-OEC ST -LRB- Pb0 .001 ; Fig. 4D -RRB- and a-OEC ST	33433
@NP	b-OEC ST -LRB- Pb0 .001 ; Fig. 4D -RRB-	33438
@NP	b-OEC	33438
@NP	ST -LRB- Pb0 .001 ; Fig. 4D -RRB-	33444
@NP	ST	33444
@NP	Pb0 .001 ; Fig. 4D	33448
@NP	Pb0 .001	33448
@NP	Fig. 4D	33457
@NP	a-OEC ST	33470
@NP	Pb0 .05 ; Fig. 4D	33480
@NP	Pb0 .05	33480
@NP	Fig. 4D	33488
@NP	It	33498
@NP	a significant neuroprotective effect on red nucleus neurons	33532
@NP	a significant neuroprotective effect	33532
@NP	red nucleus neurons	33572
@NP	transplantation of short-term cultured OEC	33593
@NP	transplantation	33593
@NP	short-term cultured OEC	33612
@NP	short-term	33612
@NP	OEC	33632
@NP	rubrospinal terminals rostral	33678
@NP	the injury site	33711
@NP	13 weeks after SCI	33731
@NP	13 weeks	33731
@NP	SCI	33746
@NP	pan-neurofilament	33751
@NP	panNF	33770
@NP	immunolabeling	33777
@NP	only single nerve fibers	33801
@NP	the lesion site	33829
@NP	BDA injections into the red nucleus	33846
@NP	BDA injections	33846
@NP	the red nucleus	33866
@NP	rubrospinal axons	33908
@NP	the rostral border of the trauma zone	33937
@NP	the rostral border	33937
@NP	the trauma zone	33959
@NP	their direction	34001
@NP	parallel	34029
@NP	the scar tissue towards the contralateral gray matter -LRB- data not shown -RRB-	34041
@NP	the scar tissue	34041
@NP	the contralateral gray matter -LRB- data not shown -RRB-	34065
@NP	the contralateral gray matter	34065
@NP	data not shown	34096
@NP	data	34096
@NP	Surprisingly and despite the marked survival effect	34113
@NP	the marked survival	34138
@NP	rubrospinal neurons , transplantation of b-OEC ST	34168
@NP	rubrospinal neurons	34168
@NP	transplantation of b-OEC ST	34189
@NP	transplantation	34189
@NP	b-OEC ST	34208
@NP	regrowth neither of panNF-immunolabeled nerve fibers	34228
@NP	regrowth	34228
@NP	panNF-immunolabeled nerve fibers	34248
@NP	rubrospinal axons -LRB- Fig. 5A , C -RRB-	34285
@NP	rubrospinal axons	34285
@NP	Fig. 5A , C	34304
@NP	Fig. 5A	34304
@NP	C	34312
@NP	The same negative results	34316
@NP	a-OEC LT -LRB- Fig. 5B , D -RRB-	34366
@NP	a-OEC LT	34366
@NP	Fig. 5B , D	34376
@NP	Fig. 5B	34376
@NP	D	34384
@NP	contrast , at 8 -- 13 weeks after transplantation of a-OEC ST	34391
@NP	contrast	34391
@NP	at 8 -- 13 weeks after transplantation of a-OEC ST	34401
@NP	at 8	34401
@NP	13 weeks after transplantation of a-OEC ST	34406
@NP	13 weeks	34406
@NP	transplantation of a-OEC ST	34421
@NP	transplantation	34421
@NP	a-OEC ST	34440
@NP	numerous panNF-positive fibers	34450
@NP	the lesion site -LRB- Fig. 5E , G -RRB-	34489
@NP	the lesion site	34489
@NP	Fig. 5E , G	34506
@NP	Fig. 5E	34506
@NP	G	34514
@NP	the trauma zone -LRB- Fig. 5F , H -RRB-	34537
@NP	the trauma zone	34537
@NP	Fig. 5F , H	34554
@NP	Fig. 5F	34554
@NP	H	34562
@NP	BDA-labeled rubrospinal axons -LRB- Fig. 6A -- C -RRB-	34566
@NP	BDA-labeled rubrospinal axons	34566
@NP	Fig. 6A -- C	34597
@NP	Fig. 6A	34597
@NP	C	34605
@NP	serotonin-positive raphaespinal axons -LRB- Fig. 6E -- I -RRB-	34612
@NP	serotonin-positive raphaespinal axons	34612
@NP	Fig. 6E -- I	34651
@NP	Fig. 6E	34651
@NP	I	34659
@NP	the injury site	34670
@NP	the lateral border	34692
@NP	1500 μm in the white and gray matter of the distal spinal cord	34735
@NP	1500 μm	34735
@NP	the white and gray matter of the distal spinal cord	34746
@NP	the white and gray matter	34746
@NP	the distal spinal cord	34775
@NP	Sensory axons immunostained for calcitonin gene-related peptide -LRB- CGRP -RRB-	34799
@NP	Sensory axons	34799
@NP	calcitonin gene-related peptide	34831
@NP	CGRP	34864
@NP	the trauma zone -LRB- Fig. 6D -RRB-	34895
@NP	the trauma zone	34895
@NP	Fig. 6D	34912
@NP	the method of culture preparation	34928
@NP	the method	34928
@NP	culture preparation	34942
@NP	growth-promoting effect of OEC	34978
@NP	growth-promoting effect	34978
@NP	OEC	35005
@NP	intraspinal transplantation	35015
@NP	Discussion The present study	35045
@NP	Discussion	35045
@NP	The present study	35056
@NP	the age of cells in culture and the method of cell purification	35085
@NP	the age	35085
@NP	cells in culture and the method of cell purification	35096
@NP	cells in culture	35096
@NP	cells	35096
@NP	culture	35105
@NP	the method of cell purification	35117
@NP	the method	35117
@NP	cell purification	35131
@NP	the neuroprotective and growth-promoting effects of OEC transplants	35165
@NP	the neuroprotective and growth-promoting effects	35165
@NP	OEC transplants	35217
@NP	purified OEC	35243
@NP	several months in culture	35278
@NP	several months	35278
@NP	culture	35296
@NP	their p75 and S100 immunoreactivity	35319
@NP	only short-term cultured cells	35356
@NP	only short-term	35356
@NP	cells	35381
@NP	massive retrograde cell death in the red nucleus	35398
@NP	massive retrograde cell death	35398
@NP	the red nucleus	35431
@NP	rubrospinal terminals	35474
@NP	cervical spinal cord injury	35502
@NP	Long-term cultured OEC	35531
@NP	Long-term	35531
@NP	OEC	35550
@NP	no effect on neuronal survival and regeneration	35558
@NP	no effect	35558
@NP	neuronal survival and regeneration	35571
@NP	p75 immunoreactivity	35611
@NP	the injection sites	35656
@NP	short-term	35691
@NP	OEC	35711
@NP	a method of differential cell adhesion	35729
@NP	a method	35729
@NP	differential cell adhesion	35741
@NP	immunomagnetic beads	35777
@NP	different effects on axonal growth	35802
@NP	different effects	35802
@NP	axonal growth	35823
@NP	OEC separated with Dynabeads -LRB- b-OEC -RRB-	35838
@NP	OEC	35838
@NP	Dynabeads	35857
@NP	b-OEC	35868
@NP	regrowth	35893
@NP	the lesion site	35909
@NP	the number of rubrospinal fibers in the white matter rostral	35939
@NP	the number	35939
@NP	rubrospinal fibers in the white matter rostral	35953
@NP	rubrospinal fibers	35953
@NP	the white matter rostral	35975
@NP	the hemisection	36003
@NP	contrast	36023
@NP	OEC	36033
@NP	a method of differential adhesion -LRB- a-OEC -RRB-	36051
@NP	a method	36051
@NP	differential adhesion -LRB- a-OEC -RRB-	36063
@NP	differential adhesion	36063
@NP	a-OEC	36086
@NP	growth	36105
@NP	the descending rubrospinal and raphaespinal tracts	36117
@NP	the descending rubrospinal	36117
@NP	raphaespinal tracts	36148
@NP	the sensory CGRPpositive fibers	36177
@NP	addition	36213
@NP	intraspinal transplantation	36229
@NP	OEC	36266
@NP	very limited migration	36277
@NP	the injection sites	36325
@NP	the trauma zone	36352
@NP	accordance with previous report -LRB- Lu et al. , 2006 -RRB-	36381
@NP	accordance	36381
@NP	previous report -LRB- Lu et al. , 2006 -RRB-	36397
@NP	previous report	36397
@NP	Lu	36414
@NP	et al. , 2006	36417
@NP	et al.	36417
@NP	2006	36425
@NP	the trauma zone	36432
@NP	injection sites	36472
@NP	narrow tract formed by transplanted OEC	36491
@NP	narrow tract	36491
@NP	transplanted OEC	36514
@NP	Factors determining the outcome of OEC transplantation Transplantation of OEC	36532
@NP	Factors	36532
@NP	the outcome of OEC transplantation Transplantation of OEC	36552
@NP	the outcome	36552
@NP	OEC transplantation Transplantation of OEC	36567
@NP	OEC transplantation Transplantation	36567
@NP	OEC	36606
@NP	axonal regeneration , myelination and neuronal survival	36636
@NP	different experimental models	36694
@NP	spinal cord injury	36727
@NP	Fouad	36747
@NP	et al. , 2009a	36753
@NP	et al.	36753
@NP	2009a	36761
@NP	Kocsis et al. , 2009	36768
@NP	Kocsis	36768
@NP	et al. , 2009	36775
@NP	et al.	36775
@NP	2009	36783
@NP	Lindsay et al. , 2010	36789
@NP	Lindsay	36789
@NP	et al. , 2010	36797
@NP	et al.	36797
@NP	2010	36805
@NP	Munoz-Quiles et al. , 2009	36811
@NP	Munoz-Quiles	36811
@NP	et al. , 2009	36824
@NP	et al.	36824
@NP	2009	36832
@NP	Radtke and Wewetzer , 2009	36838
@NP	Radtke and Wewetzer	36838
@NP	2009	36859
@NP	The conflicting data	37370
@NP	the ability	37401
@NP	OEC	37416
@NP	axonal regeneration	37431
@NP	Barnett and Riddell	37471
@NP	2007 ; Nieto-Sampedro , 2003 ; Raisman and Li , 2007 ; Richter and Roskams	37492
@NP	2007	37492
@NP	Nieto-Sampedro , 2003 ; Raisman and Li , 2007 ; Richter and Roskams	37498
@NP	Nieto-Sampedro , 2003	37498
@NP	Nieto-Sampedro	37498
@NP	2003	37514
@NP	Raisman and Li , 2007	37520
@NP	Raisman and Li	37520
@NP	2007	37536
@NP	Richter and Roskams	37542
@NP	Richter	37542
@NP	Roskams	37554
@NP	2008	37563
@NP	the factors which could potentially determine the outcome of OEC transplantation	37573
@NP	the factors	37573
@NP	the outcome of OEC transplantation	37619
@NP	the outcome	37619
@NP	OEC transplantation	37634
@NP	direct comparisons	38244
@NP	the same experimental model between differently composed cell grafts	38271
@NP	the same experimental model	38271
@NP	cell grafts	38328
@NP	the donor age , the purity of the cells	38354
@NP	the donor age	38354
@NP	the purity of the cells	38369
@NP	the purity	38369
@NP	the cells	38383
@NP	the presence of an endogenously produced matrix	38397
@NP	the presence	38397
@NP	an endogenously produced matrix	38413
@NP	the discrepancy	38464
@NP	results	38483
@NP	OEC transplant studies	38500
@NP	Andrews and Stelzner , 2004 ; Deumens et al. , 2006 ; Toft et al. , 2007	38524
@NP	Andrews and Stelzner	38524
@NP	2004 ; Deumens et al. , 2006 ; Toft et al.	38546
@NP	2004	38546
@NP	Deumens et al. , 2006 ; Toft et al.	38552
@NP	Deumens	38552
@NP	et al. , 2006 ; Toft et al.	38560
@NP	et al. , 2006	38560
@NP	et al.	38560
@NP	2006	38568
@NP	Toft et al.	38574
@NP	Toft	38574
@NP	et al.	38579
@NP	2007	38587
@NP	the initial findings	38599
@NP	OEC from the lamina propria	38625
@NP	OEC	38625
@NP	the lamina propria	38634
@NP	spinal cord repair than the cells	38677
@NP	spinal cord repair	38677
@NP	the cells	38701
@NP	the olfactory bulb	38716
@NP	Richter	38736
@NP	et al. , 2005	38744
@NP	et al.	38744
@NP	2005	38752
@NP	a subsequent study -LRB- Lu et al. , 2006 -RRB-	38785
@NP	a subsequent study	38785
@NP	Lu	38805
@NP	et al. , 2006	38808
@NP	et al.	38808
@NP	2006	38816
@NP	studies dealing with demyelination in the rat and porcine spinal cord	38835
@NP	studies	38835
@NP	demyelination in the rat and porcine spinal cord	38856
@NP	demyelination	38856
@NP	the rat and porcine spinal cord	38873
@NP	it	38906
@NP	the purity of cell cultures and the senescence of OEC	38929
@NP	the purity of cell cultures	38929
@NP	the purity	38929
@NP	cell cultures	38943
@NP	the senescence of OEC	38961
@NP	the senescence	38961
@NP	OEC	38979
@NP	remyelination -LRB- Lakatos et al. , 2003 ; Radtke et al. , 2010 -RRB-	39013
@NP	remyelination	39013
@NP	Lakatos	39028
@NP	et al. , 2003 ; Radtke et al. , 2010	39036
@NP	et al.	39036
@NP	2003 ; Radtke et al.	39044
@NP	2003	39044
@NP	Radtke et al.	39050
@NP	Radtke	39050
@NP	et al.	39057
@NP	2010	39065
@NP	The results of the present study	39072
@NP	The results	39072
@NP	the present study	39087
@NP	previous observations	39123
@NP	cell cultures	39160
@NP	stimulatory effect of OEC	39181
@NP	stimulatory effect	39181
@NP	OEC	39203
@NP	addition	39215
@NP	the technique of cell purification	39242
@NP	the technique	39242
@NP	cell purification	39259
@NP	growthpromoting effect of OEC	39292
@NP	growthpromoting effect	39292
@NP	OEC	39318
@NP	transplantation	39328
@NP	spinal cord	39349
@NP	Long-term cultured OEC	39362
@NP	Long-term	39362
@NP	OEC	39381
@NP	regeneration and neuronal survival	39403
@NP	The mechanisms	39438
@NP	the lack of neurotrophic and growthpromoting effects of long-term cultured OEC	39464
@NP	the lack	39464
@NP	neurotrophic and growthpromoting effects of long-term cultured OEC	39476
@NP	neurotrophic and growthpromoting effects	39476
@NP	long-term cultured OEC	39520
@NP	long-term	39520
@NP	OEC	39539
@NP	They	39558
@NP	the low survival rate of transplanted OEC -LRB- Pearse et al. , 2007 -RRB-	39586
@NP	the low survival rate	39586
@NP	transplanted OEC -LRB- Pearse et al. , 2007 -RRB-	39611
@NP	transplanted OEC	39611
@NP	Pearse	39629
@NP	et al. , 2007	39636
@NP	et al.	39636
@NP	2007	39644
@NP	the loss	39657
@NP	certain classes of surface receptors	39669
@NP	certain classes	39669
@NP	surface receptors	39688
@NP	interaction	39730
@NP	surrounding glial cells , macrophages and regenerating axons	39747
@NP	surrounding glial cells	39747
@NP	macrophages	39772
@NP	regenerating axons	39788
@NP	this respect	39811
@NP	the results	39825
@NP	OEC	39856
@NP	their p75 immunoreactivity	39867
@NP	several months	39898
@NP	transplantation sited with long-term cultured OEC	39923
@NP	transplantation	39923
@NP	long-term cultured OEC	39950
@NP	long-term	39950
@NP	OEC	39969
@NP	lower levels of p75 expression	39978
@NP	lower levels	39978
@NP	p75 expression	39994
@NP	cells	40039
@NP	it	40052
@NP	contrast to primate OEC	40094
@NP	contrast	40094
@NP	primate OEC	40106
@NP	adult rat and porcine OEC	40119
@NP	adult rat	40119
@NP	porcine OEC	40133
@NP	3 -- 5 weeks in culture	40182
@NP	3	40182
@NP	5 weeks in culture	40184
@NP	5 weeks	40184
@NP	culture	40195
@NP	their phenotypic properties	40212
@NP	Radtke	40241
@NP	et al. , 2010 ; Rubio et al. , 2008	40248
@NP	et al.	40248
@NP	2010 ; Rubio et al.	40256
@NP	2010	40256
@NP	Rubio et al.	40262
@NP	Rubio	40262
@NP	et al.	40268
@NP	2008	40276
@NP	it	40293
@NP	culture period	40319
@NP	several weeks	40350
@NP	senescence	40371
@NP	OEC	40383
@NP	division	40398
@NP	spontaneous immortalization	40419
@NP	Rubio	40448
@NP	et al. , 2008 ; Sonigra et al. , 1996	40454
@NP	et al.	40454
@NP	2008 ; Sonigra et al.	40462
@NP	2008	40462
@NP	Sonigra et al.	40468
@NP	Sonigra	40468
@NP	et al.	40476
@NP	1996	40484
@NP	This hypothesis	41036
@NP	findings	41068
@NP	extracellular BDNF	41082
@NP	significant amounts	41116
@NP	the early passage OEC	41139
@NP	the neurotrophin	41169
@NP	the extracellular medium	41199
@NP	the late passage cells -LRB- Pastrana et al. , 2007 -RRB-	41239
@NP	the late passage cells	41239
@NP	Pastrana	41263
@NP	et al. , 2007	41272
@NP	et al.	41272
@NP	2007	41280
@NP	long-term cultured OEC	41297
@NP	long-term	41297
@NP	OEC	41316
@NP	very low levels	41325
@NP	matrix metalloproteinase-2	41344
@NP	an important modulator of OEC-mediated axonal regeneration	41389
@NP	an important modulator	41389
@NP	OEC-mediated axonal regeneration	41415
@NP	Pastrana	41449
@NP	et al. , 2006	41458
@NP	et al.	41458
@NP	2006	41466
@NP	The latter results	41473
@NP	line	41499
@NP	observations	41509
@NP	long-term cultured OEC	41527
@NP	long-term	41527
@NP	OEC	41546
@NP	neurite outgrowth	41581
@NP	Au et al. , 2007 ; Pastrana et al. , 2006 , 2007	41609
@NP	Au et al.	41609
@NP	Au	41609
@NP	et al.	41612
@NP	2007 ; Pastrana et al.	41620
@NP	2007	41620
@NP	Pastrana et al.	41626
@NP	Pastrana	41626
@NP	et al.	41635
@NP	2006 , 2007	41643
@NP	2006	41643
@NP	2007	41649
@NP	a new growth-promoting factor	41665
@NP	the SPARC -LRB- secreted protein acidic rich in cystein -RRB-	41696
@NP	the SPARC	41696
@NP	protein acidic rich	41716
@NP	protein	41716
@NP	cystein	41739
@NP	osteonectin	41749
@NP	OEC conditioned medium -LRB- Au et al. , 2007 -RRB-	41786
@NP	OEC conditioned medium	41786
@NP	Au	41810
@NP	et al. , 2007	41813
@NP	et al.	41813
@NP	2007	41821
@NP	It	41828
@NP	SPARC	41858
@NP	an OEC-derived matricellular protein	41867
@NP	the ability of Schwann cells	41935
@NP	the ability	41935
@NP	Schwann cells	41950
@NP	axonal regeneration via laminin-1 and TGFβ signaling	41977
@NP	axonal regeneration	41977
@NP	laminin-1 and TGFβ signaling	42001
@NP	it	42040
@NP	early P2 passage OEC	42068
@NP	30	42094
@NP	50 % higher levels	42097
@NP	SPARC expression than late P6 passage cells -LRB- Au et al. , 2007 -RRB-	42118
@NP	SPARC expression	42118
@NP	late P6 passage cells -LRB- Au et al. , 2007 -RRB-	42140
@NP	late P6 passage cells	42140
@NP	Au	42163
@NP	et al. , 2007	42166
@NP	et al.	42166
@NP	2007	42174
@NP	respect to neuroprotective effect of the short-term cultured OEC	42186
@NP	respect	42186
@NP	neuroprotective effect of the short-term cultured OEC	42197
@NP	neuroprotective effect	42197
@NP	the short-term cultured OEC	42223
@NP	the short-term	42223
@NP	OEC	42247
@NP	our findings	42252
@NP	line with previous reports	42272
@NP	line	42272
@NP	previous reports	42282
@NP	OEC transplantation into the injured spinal cord	42304
@NP	OEC transplantation	42304
@NP	the injured spinal cord	42329
@NP	corticospinal neurons	42378
@NP	retrograde degeneration -LRB- Sasaki et al. , 2006 -RRB-	42405
@NP	retrograde degeneration	42405
@NP	Sasaki	42430
@NP	et al. , 2006	42437
@NP	et al.	42437
@NP	2006	42445
@NP	Biochemical analysis performed in the latter study	42452
@NP	Biochemical analysis	42452
@NP	the latter study	42486
@NP	levels of BDNF	42538
@NP	levels	42538
@NP	BDNF	42548
@NP	the spinal cord injury zone	42556
@NP	1 week after OEC transplantation	42587
@NP	1 week	42587
@NP	OEC transplantation	42600
@NP	no difference	42624
@NP	NGF and NT-3 levels	42653
@NP	olfactory neural progenitors	42684
@NP	the olfactory mucosa	42718
@NP	the capacity to generate both neurons and OEC	42745
@NP	both neurons and OEC	42770
@NP	neurons	42775
@NP	OEC	42787
@NP	BDNF	42819
@NP	red nucleus neurons	42849
@NP	SCI -LRB- Xiao et al. , 2005 -RRB-	42875
@NP	SCI	42875
@NP	Xiao	42880
@NP	et al. , 2005	42885
@NP	et al.	42885
@NP	2005	42893
@NP	It	42900
@NP	neurotrophic factors	42934
@NP	retrograde degeneration	42978
@NP	regeneration	43019
@NP	rubrospinal neurons	43035
@NP	different models	43058
@NP	spinal cord injury	43078
@NP	Kobayashi	43098
@NP	et al. , 1997	43108
@NP	et al.	43108
@NP	1997	43116
@NP	Novikova et al. , 2000	43122
@NP	Novikova	43122
@NP	et al. , 2000	43131
@NP	et al.	43131
@NP	2000	43139
@NP	Storer et al. , 2003	43145
@NP	Storer	43145
@NP	et al. , 2003	43152
@NP	et al.	43152
@NP	2003	43160
@NP	Tobias et al. , 2003	43166
@NP	Tobias	43166
@NP	et al. , 2003	43173
@NP	et al.	43173
@NP	2003	43181
@NP	varying outcomes of rubrospinal regeneration	43197
@NP	varying outcomes	43197
@NP	rubrospinal regeneration	43217
@NP	OEC transplantation	43267
@NP	complete spinal cord transection -LRB- Cao et al. , 2004 -RRB-	43298
@NP	complete spinal cord transection	43298
@NP	Cao	43332
@NP	et al. , 2004	43336
@NP	et al.	43336
@NP	2004	43344
@NP	moderate contusion injury -LRB- Plant et al. , 2003 -RRB-	43353
@NP	moderate contusion injury	43353
@NP	Plant	43380
@NP	et al. , 2003	43386
@NP	et al.	43386
@NP	2003	43394
@NP	significant increase in the number of retrogradely labeled neurons	43401
@NP	significant increase	43401
@NP	the number of retrogradely labeled neurons	43425
@NP	the number	43425
@NP	retrogradely labeled neurons	43439
@NP	the red nucleus	43487
@NP	The present study	43504
@NP	growth-promoting effect of short-term cultured a-OEC on rubrospinal neurons	43540
@NP	growth-promoting effect	43540
@NP	short-term cultured a-OEC on rubrospinal neurons	43567
@NP	short-term	43567
@NP	a-OEC	43587
@NP	rubrospinal neurons	43596
@NP	contrast	43620
@NP	less-severe injury to the dorsolateral funiculus	43636
@NP	less-severe injury	43636
@NP	the dorsolateral funiculus	43658
@NP	anterograde tracing	43686
@NP	anterograde	43686
@NP	no regeneration of rubrospinal axons across the lesion site	43714
@NP	no regeneration	43714
@NP	rubrospinal axons across the lesion site	43733
@NP	rubrospinal axons	43733
@NP	the lesion site	43758
@NP	the distal cord -LRB- Bretzner et al. , 2010 ; Ruitenberg et al. , 2003 -RRB-	43779
@NP	the distal cord	43779
@NP	Bretzner	43796
@NP	et al. , 2010 ; Ruitenberg et al. , 2003	43805
@NP	et al.	43805
@NP	2010 ; Ruitenberg et al.	43813
@NP	2010	43813
@NP	Ruitenberg et al.	43819
@NP	Ruitenberg	43819
@NP	et al.	43830
@NP	2003	43838
@NP	Method of cell purification	43845
@NP	Method	43845
@NP	cell purification	43855
@NP	growth-promoting effect	43886
@NP	OEC transplant	43913
@NP	The limited effects of b-OEC on regeneration	43928
@NP	The limited effects	43928
@NP	b-OEC on regeneration	43951
@NP	b-OEC	43951
@NP	regeneration	43960
@NP	it	43997
@NP	the same method of purification with immunomagnetic Dynabeads	44031
@NP	the same method	44031
@NP	purification with immunomagnetic Dynabeads	44050
@NP	purification	44050
@NP	immunomagnetic Dynabeads	44068
@NP	OEC grafts	44104
@NP	significant regenerative response	44135
@NP	transplantation	44175
@NP	rat spinal cord -LRB- Lopez-Vales et al. , 2006 , 2007 -RRB-	44218
@NP	rat spinal cord	44218
@NP	Lopez-Vales	44235
@NP	et al. , 2006 , 2007	44247
@NP	et al.	44247
@NP	2006	44255
@NP	2007	44261
@NP	immunomagnetic beads separate only OEC	44277
@NP	immunomagnetic beads	44277
@NP	separate only OEC	44298
@NP	sufficiently strong expression of p75 receptors	44321
@NP	sufficiently strong expression	44321
@NP	p75 receptors	44355
@NP	all other OEC subtypes	44377
@NP	the supernatant	44403
@NP	It	44420
@NP	the major OEC population in primary cells suspensions	44455
@NP	the major OEC population	44455
@NP	primary cells suspensions	44483
@NP	p75 receptors	44536
@NP	them	44566
@NP	several days in culture -LRB- Wewetzer et al. , 2005 -RRB-	44577
@NP	several days	44577
@NP	culture -LRB- Wewetzer et al. , 2005 -RRB-	44593
@NP	culture	44593
@NP	Wewetzer	44602
@NP	et al. , 2005	44611
@NP	et al.	44611
@NP	2005	44619
@NP	it	44632
@NP	contrast to previous reports -LRB- Lopez-Vales et al. , 2006 , 2007 -RRB-	44655
@NP	contrast	44655
@NP	previous reports -LRB- Lopez-Vales et al. , 2006 , 2007 -RRB-	44667
@NP	previous reports	44667
@NP	Lopez-Vales	44685
@NP	et al. , 2006 , 2007	44697
@NP	et al.	44697
@NP	2006	44705
@NP	2007	44711
@NP	we	44718
@NP	different subtypes of OEC which had marked neuroprotective effect	44731
@NP	different subtypes	44731
@NP	OEC	44753
@NP	neuroprotective effect	44774
@NP	axonal regrowth	44819
@NP	Another possibility	44836
@NP	the cell	44877
@NP	surface Dynabeads	44886
@NP	the processes of interaction between transplanted OEC	44925
@NP	the processes	44925
@NP	interaction between transplanted OEC	44942
@NP	interaction	44942
@NP	transplanted OEC	44962
@NP	host cells including reactive astrocytes	44995
@NP	host cells	44995
@NP	reactive astrocytes	45016
@NP	it	45046
@NP	short-term cultured a-OEC	45066
@NP	short-term	45066
@NP	a-OEC	45086
@NP	rubrospinal neurons	45123
@NP	b-OEC	45148
@NP	axonal regrowth	45197
@NP	the trauma zone	45220
@NP	One possibility	45237
@NP	the signaling pathways promoting neuronal survival and axonal regeneration	45261
@NP	the signaling pathways	45261
@NP	neuronal survival and axonal regeneration	45294
@NP	neuronal survival	45294
@NP	axonal regeneration	45316
@NP	neurotrophic factors	45359
@NP	efficient neuroprotection of axotomized neurons	45389
@NP	efficient neuroprotection	45389
@NP	neurons	45429
@NP	a sufficient prerequisite	45444
@NP	axonal regeneration -LRB- Lu et al. , 2001 ; Novikova et al. , 2002 -RRB-	45474
@NP	axonal regeneration	45474
@NP	Lu	45495
@NP	et al. , 2001 ; Novikova et al. , 2002	45498
@NP	et al.	45498
@NP	2001 ; Novikova et al.	45506
@NP	2001	45506
@NP	Novikova et al.	45512
@NP	Novikova	45512
@NP	et al.	45521
@NP	2002	45529
@NP	Another interesting observation in the present study	45536
@NP	Another interesting observation	45536
@NP	the present study	45571
@NP	the neuroprotective effect of the short-term cultured OEC	45597
@NP	the neuroprotective effect	45597
@NP	the short-term cultured OEC	45627
@NP	the short-term	45627
@NP	OEC	45651
@NP	rubrospinal sprouting	45682
@NP	rubrospinal	45682
@NP	The same effects on lesioned rubrospinal neurons	45705
@NP	The same effects	45705
@NP	lesioned rubrospinal neurons	45725
@NP	prolonged intrathecal infusion	45791
@NP	BDNF and NT-3 -LRB- Novikova et al. , 2002 -RRB-	45825
@NP	BDNF and NT-3	45825
@NP	Novikova	45840
@NP	et al. , 2002	45849
@NP	et al.	45849
@NP	2002	45857
@NP	summary	45867
@NP	the present study	45876
@NP	the age of cells in culture and the method of cell purification	45912
@NP	the age	45912
@NP	cells in culture and the method of cell purification	45923
@NP	cells in culture	45923
@NP	cells	45923
@NP	culture	45932
@NP	the method of cell purification	45944
@NP	the method	45944
@NP	cell purification	45958
@NP	influence	45981
@NP	the growth-promoting and neuroprotective effects of OEC after transplantation	45994
@NP	the growth-promoting and neuroprotective effects	45994
@NP	OEC after transplantation	46046
@NP	OEC	46046
@NP	transplantation	46056
@NP	the injured spinal cord	46077
@NP	The finding	46102
@NP	methods of culture preparation	46119
@NP	methods	46119
@NP	culture preparation	46130
@NP	the outcome of OEC transplantation	46163
@NP	the outcome	46163
@NP	OEC transplantation	46178
@NP	an important issue	46207
@NP	human trials with OEC	46232
@NP	human trials	46232
@NP	OEC	46250
@NP	several countries -LRB- Dobkin et al. , 2006 ; Kay-Sim et al. , 2008 -RRB-	46277
@NP	several countries	46277
@NP	Dobkin	46296
@NP	et al. , 2006 ; Kay-Sim et al. , 2008	46303
@NP	et al.	46303
@NP	2006 ; Kay-Sim et al.	46311
@NP	2006	46311
@NP	Kay-Sim et al.	46317
@NP	Kay-Sim	46317
@NP	et al.	46325
@NP	2008	46333
@VP	to support regeneration after spinal cord injury	41
@VP	support regeneration after spinal cord injury	44
@VP	is influenced by method of culture preparation Liudmila N.	90
@VP	influenced by method of culture preparation Liudmila N.	93
@VP	have challenged this treatment strategy	671
@VP	challenged this treatment strategy	676
@VP	could be attributed to many factors including variations in culture protocols	739
@VP	be attributed to many factors including variations in culture protocols	745
@VP	attributed to many factors including variations in culture protocols	748
@VP	purified using method of differential cell adhesion -LRB- a-OEC -RRB-	1042
@VP	using method of differential cell adhesion -LRB- a-OEC -RRB-	1051
@VP	separated with immunomagnetic beads -LRB- b-OEC -RRB-	1105
@VP	cultured OEC	1239
@VP	labeled OEC	1385
@VP	were mainly found in the injection sites and in the trauma zone	1397
@VP	found in the injection sites and in the trauma zone	1409
@VP	cultured a-OEC	1473
@VP	supported regrowth of rubrospinal , raphaespinal and CGRP-positive fibers	1488
@VP	attenuated retrograde degeneration in the red nucleus	1566
@VP	cultured b-OEC	1631
@VP	failed to promote axonal regrowth	1646
@VP	to promote axonal regrowth	1653
@VP	promote axonal regrowth	1656
@VP	increased the density of rubrospinal axons within the dorsolateral funiculus	1684
@VP	provided significant neuroprotection for axotomized rubrospinal neurons	1765
@VP	cultured OEC	1862
@VP	attenuated sprouting of rubrospinal terminals	1875
@VP	sprouting of rubrospinal terminals	1886
@VP	cultured OEC neither enhanced axonal growth nor prevented retrograde cell death	1945
@VP	cultured OEC neither enhanced axonal growth	1945
@VP	enhanced axonal growth	1966
@VP	prevented retrograde cell death	1993
@VP	to support neuronal survival and regeneration after spinal cord injury	2146
@VP	support neuronal survival and regeneration after spinal cord injury	2149
@VP	is part of a Special Issue entitled	2231
@VP	entitled	2258
@VP	results in nearly complete failure of the severed axons to regenerate	2426
@VP	to regenerate	2482
@VP	regenerate	2485
@VP	eventually results in cyst formation and enlargement of the trauma zone	2656
@VP	generated by microglia	2771
@VP	to secrete proteoglycans	2824
@VP	secrete proteoglycans	2827
@VP	to form glial scar -LRB- Busch et al. , 2010 ; Fitch and Silver , 2008 -RRB-	2853
@VP	form glial scar -LRB- Busch et al. , 2010 ; Fitch and Silver , 2008 -RRB-	2856
@VP	occurs in the lesioned spinal tracts -LRB- Deumens et al. , 2005 -RRB-	2955
@VP	Severed	3016
@VP	are limited by inhibitory nature of myelin and the glial scar	3030
@VP	limited by inhibitory nature of myelin and the glial scar	3034
@VP	To achieve regeneration after spinal cord injury	3221
@VP	achieve regeneration after spinal cord injury	3224
@VP	minimizing inhibitory signals in the trauma zone	3323
@VP	reducing secondary degeneration , scarring and cavitation	3373
@VP	bridging spinal cord tissue gaps	3431
@VP	stimulating guided axonal growth across the lesion site	3468
@VP	guided axonal growth across the lesion site	3480
@VP	bridging nerve grafts and neurotrophic factors	3714
@VP	are not completely understood	4420
@VP	completely understood	4428
@VP	stimulate Schwann cells to support neurite outgrowth	4595
@VP	to support neurite outgrowth	4619
@VP	support neurite outgrowth	4622
@VP	enhance spinal cord repair -LRB- Au et al. , 2007 -RRB-	4652
@VP	are unlikely to provide a panacea for spinal cord repair	4903
@VP	to provide a panacea for spinal cord repair	4916
@VP	provide a panacea for spinal cord repair	4919
@VP	sprouting	5881
@VP	used in culture preparation	6234
@VP	could also influence the outcome of OEC transplantation	6467
@VP	influence the outcome of OEC transplantation	6478
@VP	harvested from the adult rat olfactory bulbs	6567
@VP	could stimulate axonal regrowth across the lesion site and support survival	6802
@VP	stimulate axonal regrowth across the lesion site and support survival	6808
@VP	will require large quantities of OEC	7037
@VP	require large quantities of OEC	7042
@VP	, therefore , could increase the time in culture	7077
@VP	increase the time in culture	7096
@VP	cultured cells	7211
@VP	approved by the Northern Swedish Committee for Ethics in Animal Experiments	7540
@VP	were separated under the microscope	8337
@VP	separated under the microscope	8342
@VP	cut into small pieces and collected into Ca2	8374
@VP	cut into small pieces	8374
@VP	collected into Ca2	8400
@VP	washing inHBSS	8446
@VP	dissociated using 0.1 % trypsin for 15 min at 37 °C	8476
@VP	using 0.1 % trypsin for 15 min at 37 °C	8488
@VP	supplemented with 2	8658
@VP	contained a mixture of OEC , fibroblasts , endothelial cells and astrocytes	9063
@VP	obtained from each pair of OB	9501
@VP	resuspended in D/F -10 S culture medium	9535
@VP	cultured at 37 °C with 5 % CO2	9657
@VP	removed and replated on another uncoated Lab-Tek ® slide	9720
@VP	incubated for additional 36 -- 48 h.	9780
@VP	removed	9894
@VP	re-plated on 25 cm2	9906
@VP	attached to the uncoated chamber slides -LRB- Nash et al. , 2001 -RRB-	10038
@VP	to allow OEC to adhere to the poly-Llysine - coated surface of culture flask	10142
@VP	allow OEC to adhere to the poly-Llysine - coated surface of culture flask	10145
@VP	to adhere to the poly-Llysine - coated surface of culture flask	10155
@VP	adhere to the poly-Llysine - coated surface of culture flask	10158
@VP	removing the medium	10225
@VP	were washed with Ca2 + and Mg2 + - free HBSS	10255
@VP	washed with Ca2 + and Mg2 + - free HBSS	10260
@VP	was 93 -- 95 %	10327
@VP	was performed on 1	10378
@VP	performed on 1	10382
@VP	were placed on 25 cm2 poly-Llysine - coated culture flasks	10893
@VP	placed on 25 cm2 poly-Llysine - coated culture flasks	10898
@VP	kept at 37 °C , 95 % humidity and 5 % CO2	10955
@VP	was about 80 %	11025
@VP	was changed every second day	11581
@VP	changed every second day	11585
@VP	were maintained in culture for 20 weeks	11645
@VP	maintained in culture for 20 weeks	11650
@VP	seeded	11843
@VP	described previously by Rubio et al. , 2008 -RRB-	11860
@VP	cultured cells , OEC LT	12057
@VP	were expanded using growth medium D/F -10 S with forskolin and GGF2	12091
@VP	expanded using growth medium D/F -10 S with forskolin and GGF2	12096
@VP	using growth medium D/F -10 S with forskolin and GGF2	12105
@VP	cultured for 7 and 20 weeks	12216
@VP	using immunostaining for p75 receptors and S100 protein -LRB- see below -RRB-	12407
@VP	see below	12464
@VP	dye Fast Blue -LRB- Sigma-Aldrich Sweden AB , Stockholm , Sweden -RRB-	12730
@VP	were detached from culture flasks with Trypsin/EDTA	12796
@VP	detached from culture flasks with Trypsin/EDTA	12801
@VP	concentrated in the growth medium to 1 -- 3 × 106 cells/ml	12852
@VP	added to cell suspension at concentration 5 μl/ml for 15 min at 37 °C	12920
@VP	gently washed	13022
@VP	plated in 25 cm2 poly-L-lysine-coated culture flasks with growth medium	13037
@VP	To express green fluorescent protein -LRB- GFP -RRB- in OEC -LRB- Fig. 1E -RRB-	13205
@VP	express green fluorescent protein -LRB- GFP -RRB- in OEC -LRB- Fig. 1E -RRB-	13208
@VP	used retroviral expression system	13269
@VP	transfected with a retroviral expression vector pLEGFPpuro	13543
@VP	provided by the manufacturer	13978
@VP	were selected with puromycin and maintained	14039
@VP	were selected with puromycin	14039
@VP	selected with puromycin	14044
@VP	maintained	14072
@VP	seeded at confluence about 60 %	14158
@VP	incubated overnight at 37 °C	14190
@VP	transferred into a 32 °C incubator with 95 % humidity and 5 % CO2	14223
@VP	containing medium	14306
@VP	were seeded at a density of 5 × 103 cells per cm2	14450
@VP	seeded at a density of 5 × 103 cells per cm2	14455
@VP	containing 8 μl/ml polybrene -LRB- Sigma-Aldrich , Milwaukee , USA -RRB-	14570
@VP	were kept at 32 °C for 24 h.	14642
@VP	kept at 32 °C for 24 h.	14647
@VP	was changed to a fresh OEC growth medium	14708
@VP	changed to a fresh OEC growth medium	14712
@VP	was about 40 %	14772
@VP	were transected on the left side	15127
@VP	transected on the left side	15132
@VP	receiving different treatments	15217
@VP	cultured b-OEC was not performed since our results in vitro	15593
@VP	was not performed since our results in vitro	15608
@VP	performed since our results in vitro	15616
@VP	see Results , Olfactory ensheathing cell culture	15654
@VP	served as baseline controls	16039
@VP	cultured in D/F -10 Swith	16099
@VP	detached with Trypsin/EDTA	16170
@VP	washed	16198
@VP	concentrated to 105 cells/μl in the growth mediumwithout serum	16209
@VP	attached to a 5 μl Hamiltone syringe	16350
@VP	was slowly	16446
@VP	was left in place for additional 2 -- 3 min	16685
@VP	left in place for additional 2 -- 3 min	16689
@VP	was covered with stretched parafilm	16737
@VP	covered with stretched parafilm	16741
@VP	were closed in layers	16807
@VP	closed in layers	16812
@VP	dealing with neuronal survival , rubrospinal neurons	17056
@VP	was exposed	17239
@VP	exposed	17243
@VP	was transected with a fine scissors under an operating microscope	17336
@VP	transected with a fine scissors under an operating microscope	17340
@VP	placed into the lesion cavity	17543
@VP	covered with a thin sheet of parafilm and a small piece of Spongostan ®	17577
@VP	tracing of rubrospinal axons Anterograde labeling of rubrospinal axons	17661
@VP	was performed as described by us previously -LRB- Novikova et al. , 2002 -RRB-	17732
@VP	performed as described by us previously -LRB- Novikova et al. , 2002 -RRB-	17736
@VP	described by us previously -LRB- Novikova et al. , 2002 -RRB-	17749
@VP	were mounted in a stereotaxic frame	17858
@VP	mounted in a stereotaxic frame	17863
@VP	was drilled in the skull to allow access to the red nucleus	17910
@VP	drilled in the skull to allow access to the red nucleus	17914
@VP	to allow access to the red nucleus	17935
@VP	allow access to the red nucleus	17938
@VP	biotinylated dextran amine in saline	18053
@VP	was then left in place for additional 2 -- 3 min	18576
@VP	left in place for additional 2 -- 3 min	18585
@VP	followed by 4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	18807
@VP	using anterograde BDA-labeling	18894
@VP	were then removed and transferred into the same fixative	19090
@VP	removed and transferred into the same fixative	19100
@VP	cryoprotected in 10 %	19228
@VP	frozen in liquid isopentane	19282
@VP	dried overnight at room temperature	19461
@VP	stored at − 85 °C before processing	19501
@VP	mounted on gelatin-coated glass slides	19693
@VP	dried	19737
@VP	shortly immersed in xylene	19744
@VP	coverslipped in DPX -LRB- Kebo Lab AB , Sweden -RRB-	19775
@VP	cut on a cryomicrotome or vibratome	20027
@VP	processed according to a modified ABC method -LRB- Novikova et al. , 2002 -RRB-	20067
@VP	washed in PBS	20174
@VP	containing 0.3 % Triton X-100 and 1 % bovine serum albumin	20319
@VP	mounted on glass slides	20505
@VP	counterstained with cresyl violet	20530
@VP	coverslipped in DPX	20568
@VP	cultured on Lab-Tek ® slides	20698
@VP	were applied for 2 h at room temperature	21399
@VP	applied for 2 h at room temperature	21404
@VP	rinsing in PBS , secondary goat anti-mouse and goat anti-rabbit antibodies	21447
@VP	were applied for 1 h at room temperature in the dark	21597
@VP	applied for 1 h at room temperature in the dark	21602
@VP	coverslipped with Vectashield ® mounting medium -LRB- Vector Laboratories -RRB-	21667
@VP	was tested by omission of primary antibodies	21762
@VP	tested by omission of primary antibodies	21766
@VP	labeled neurons	21897
@VP	were counted in all sections through the red nucleus at 250 × magnification	21913
@VP	counted in all sections through the red nucleus at 250 × magnification	21918
@VP	used	22134
@VP	reconstructed from serial sections -LRB- Novikov et al. , 1997 -RRB-	22375
@VP	sprouting	22492
@VP	described previously	22659
@VP	was 1280 × 1024 pixels and corresponded to the area of 54.18 × 43.35 μm	22994
@VP	was 1280 × 1024 pixels	22994
@VP	corresponded to the area of 54.18 × 43.35 μm	23019
@VP	was calculated for each section	23240
@VP	calculated for each section	23244
@VP	describing the mean number of arborizations per labeled stem axon	23429
@VP	were calculated	23495
@VP	calculated	23500
@VP	photographed with a Nikon DXM1200 digital camera attached to a Leitz microscope	23547
@VP	attached to a Leitz microscope	23596
@VP	resized	23653
@VP	grouped into a single canvas	23662
@VP	labeled using Adobe Photoshop software	23695
@VP	using Adobe Photoshop software	23703
@VP	were adjusted to provide optimal clarity	23763
@VP	adjusted to provide optimal clarity	23768
@VP	to provide optimal clarity	23777
@VP	provide optimal clarity	23780
@VP	attached to OEC in -LRB- F -RRB-	24447
@VP	are stained with DAPI	24483
@VP	stained with DAPI	24487
@VP	purified with a method of differential adhesion	24695
@VP	supplemented with forskolin and pituitary extract -LRB- Forskolin + PitExt -RRB-	24797
@VP	show S.E.M.	24987
@VP	cultured with forskolin and GGF2 for 3 and 7 weeks -LRB- PN0 .05 -RRB-	25048
@VP	shows cumulative growth rate	25122
@VP	is based on Population Doublings per week -LRB- Rubio et al. , 2008 -RRB-	25155
@VP	based on Population Doublings per week -LRB- Rubio et al. , 2008 -RRB-	25158
@VP	boxed areas in -LRB- B -RRB- and -LRB- E -RRB- , respectively	25499
@VP	Note significant reduction of p75-immunoreactivity in -LRB- I -RRB-	25674
@VP	indicate injection sites	25740
@VP	indicate trauma zones	25776
@VP	indicates Fast Blue labeling	25809
@VP	labeled with DAPI	25866
@VP	show S.E.M.	26582
@VP	is indicated by * -LRB- control vs. b-OEC ST ; a-OEC ST vs.	26609
@VP	indicated by * -LRB- control vs. b-OEC ST ; a-OEC ST vs.	26612
@VP	and Pb0 .001 is indicated by # -LRB- control vs.	26681
@VP	Pb0 .001 is indicated by # -LRB- control vs.	26685
@VP	is indicated by # -LRB- control vs.	26693
@VP	indicated by # -LRB- control vs.	26696
@VP	is indicated by * -LRB- b-OEC ST vs.	26822
@VP	indicated by * -LRB- b-OEC ST vs.	26825
@VP	is indicated by # -LRB- control and a-OEC ST vs.	26871
@VP	indicated by # -LRB- control and a-OEC ST vs.	26874
@VP	is indicated by # -LRB- a-OEC ST vs. control , SCI , b-OEC-ST and a-OEC LT -RRB-	27030
@VP	indicated by # -LRB- a-OEC ST vs. control , SCI , b-OEC-ST and a-OEC LT -RRB-	27033
@VP	is indicated by * -LRB- a-OEC ST vs.	27115
@VP	indicated by * -LRB- a-OEC ST vs.	27118
@VP	is indicated by # -LRB- control vs. experiment ; b-OEC ST vs.	27177
@VP	indicated by # -LRB- control vs. experiment ; b-OEC ST vs.	27180
@VP	immunostained for pan-neurofilament	27303
@VP	Boxed areas in -LRB- A -RRB- , -LRB- B -RRB-	27510
@VP	-LRB- E -- F -RRB- after a-OEC ST transplantation	27637
@VP	immunostained for serotonin -LRB- E -- I -RRB- at 13 weeks after cervical SCI	27832
@VP	Boxed areas in -LRB- A -RRB- and -LRB- E -RRB-	27940
@VP	are enlarged in -LRB- B -- C -RRB- and -LRB- F -- I -RRB- , respectively	27967
@VP	Note labeled rubrospinal and raphaespinal axons crossing the lesion site	28014
@VP	labeled rubrospinal and raphaespinal axons crossing the lesion site	28019
@VP	crossing the lesion site	28062
@VP	indicate trauma zones	28098
@VP	are counterstained with cresyl violet	28137
@VP	counterstained with cresyl violet	28141
@VP	contained about 35	28273
@VP	were Thy 1.1 - positive cells	28560
@VP	to maintain pure long-term cultures of a-OEC for intraspinal transplantation	28606
@VP	maintain pure long-term cultures of a-OEC for intraspinal transplantation	28609
@VP	-10 S alone or with DMEM-10S supplemented with forskolin and pituitary extract	28740
@VP	supplemented with forskolin and pituitary extract	29061
@VP	remained within 80 -- 90 % during the first week after purification	29159
@VP	reduced drastically to 15 -- 18 % -LRB- Pb0 .0001 ; Fig. 2 -RRB-	29256
@VP	supplemented with forskolin and recombinant human GGF2	29335
@VP	maintained 90 -- 95 % pure a-OEC for at least 11 weeks -LRB- Fig. 2 -RRB-	29390
@VP	resulted in most cases in 80 % OEC purity	29510
@VP	remained attached to the cell surface -LRB- Fig. 1F -RRB-	29603
@VP	attached to the cell surface -LRB- Fig. 1F -RRB-	29612
@VP	was reduced after 2 weeks in culture	29685
@VP	reduced after 2 weeks in culture	29689
@VP	not shown	29811
@VP	tested	29883
@VP	connected with both injection sites by narrow tract formed by transplanted OEC	30306
@VP	formed by transplanted OEC	30358
@VP	did not find any OEC migration rostral and caudal from the injection sites	30398
@VP	find any OEC migration rostral and caudal from the injection sites	30406
@VP	was markedly reduced at 8 weeks post-operatively -LRB- Fig. 3A and B -RRB-	30496
@VP	reduced at 8 weeks post-operatively -LRB- Fig. 3A and B -RRB-	30509
@VP	could be detected -LRB- compare Fig. 3C and D -RRB-	30648
@VP	be detected -LRB- compare Fig. 3C and D -RRB-	30654
@VP	detected -LRB- compare Fig. 3C and D -RRB-	30657
@VP	compare Fig. 3C and D	30667
@VP	be due to down regulation of GFP expression -LRB- Vroemen et al. , 2005 -RRB-	30735
@VP	also transplanted Fast Blue-labeled OEC -LRB- Pettersson et al. , 2010 -RRB-	30806
@VP	coincided with labeled cells in the transplantation sites	31128
@VP	transplanted with short-term cultured OEC	31311
@VP	cultured OEC	31340
@VP	cultured OEC	31464
@VP	labeled neuronal profiles with nucleus -LRB- mean ± S.E.M. -RRB-	31647
@VP	remained in the nucleus -LRB- Pb0 .001 ; Fig. 4A -RRB-	31905
@VP	exhibited significant cell atrophy -LRB- data not shown -RRB-	31965
@VP	not shown	32006
@VP	protected 69 % of the rubrospinal neurons -LRB- Pb0 .05 ;	32150
@VP	had no effect on retrograde cell death after SCI -LRB- Fig. 4A -RRB-	32269
@VP	sprouting	32336
@VP	was significantly reduced to 30 % of normal control	32520
@VP	reduced to 30 % of normal control	32538
@VP	had no effects -LRB- PN0 .05 ; Fig. 4B -- D -RRB-	32643
@VP	labeled rubrospinal axons in the dorsolateral funiculus	33273
@VP	cultured OEC	33623
@VP	diminished sprouting of rubrospinal terminals rostral to the injury site	33654
@VP	sprouting of rubrospinal terminals rostral to the injury site	33665
@VP	revealed only single nerve fibers in the lesion site	33792
@VP	labeled rubrospinal axons	33900
@VP	approached the rostral border of the trauma zone	33926
@VP	then suddenly changed their direction	33979
@VP	not shown	34101
@VP	were also obtained with a-OEC LT -LRB- Fig. 5B , D -RRB-	34342
@VP	obtained with a-OEC LT -LRB- Fig. 5B , D -RRB-	34352
@VP	bridged the lesion site -LRB- Fig. 5E , G -RRB-	34481
@VP	sprouted within the trauma zone -LRB- Fig. 5F , H -RRB-	34521
@VP	crossed the injury site along the lateral border	34662
@VP	immunostained for calcitonin gene-related peptide	34813
@VP	were found mainly within the trauma zone -LRB- Fig. 6D -RRB-	34870
@VP	found mainly within the trauma zone -LRB- Fig. 6D -RRB-	34875
@VP	could influence growth-promoting effect of OEC after intraspinal transplantation	34962
@VP	influence growth-promoting effect of OEC after intraspinal transplantation	34968
@VP	influence the neuroprotective and growth-promoting effects of OEC transplants	35155
@VP	losing their p75 and S100 immunoreactivity	35312
@VP	cultured cells	35372
@VP	attenuated massive retrograde cell death in the red nucleus	35387
@VP	decreased sprouting of rubrospinal terminals after cervical spinal cord injury	35451
@VP	sprouting of rubrospinal terminals after cervical spinal cord injury	35461
@VP	cultured OEC	35541
@VP	had no effect on neuronal survival and regeneration	35554
@VP	was markedly reduced in the injection sites	35632
@VP	reduced in the injection sites	35645
@VP	had different effects on axonal growth	35798
@VP	separated with Dynabeads	35842
@VP	failed to promote regrowth across the lesion site	35875
@VP	to promote regrowth across the lesion site	35882
@VP	promote regrowth across the lesion site	35885
@VP	stimulated growth from the descending rubrospinal and raphaespinal tracts	36094
@VP	labeled OEC	36258
@VP	showed very limited migration	36270
@VP	were found mainly at the injection sites and in the trauma zone	36304
@VP	found mainly at the injection sites and in the trauma zone	36309
@VP	connected with both injection sites by narrow tract formed by transplanted OEC	36452
@VP	formed by transplanted OEC	36504
@VP	determining the outcome of OEC transplantation Transplantation of OEC	36540
@VP	to support axonal regeneration have been reviewed	37420
@VP	support axonal regeneration have been reviewed	37423
@VP	have been reviewed	37451
@VP	been reviewed	37456
@VP	reviewed	37461
@VP	could potentially determine the outcome of OEC transplantation	37591
@VP	determine the outcome of OEC transplantation	37609
@VP	have been discussed	37654
@VP	been discussed	37659
@VP	discussed	37664
@VP	made in the same experimental model between differently composed cell grafts	38263
@VP	between differently composed cell grafts	38299
@VP	have not been confirmed in a subsequent study -LRB- Lu et al. , 2006 -RRB-	38758
@VP	been confirmed in a subsequent study -LRB- Lu et al. , 2006 -RRB-	38767
@VP	confirmed in a subsequent study -LRB- Lu et al. , 2006 -RRB-	38772
@VP	dealing with demyelination in the rat and porcine spinal cord	38843
@VP	influence remyelination -LRB- Lakatos et al. , 2003 ; Radtke et al. , 2010 -RRB-	39003
@VP	prolonged cell cultures reduce stimulatory effect of OEC	39150
@VP	reduce stimulatory effect of OEC	39174
@VP	modulate growthpromoting effect of OEC after transplantation into spinal cord	39283
@VP	cultured OEC	39372
@VP	cultured OEC	39530
@VP	are not clear	39543
@VP	retain their p75 immunoreactivity for several months in vitro	39860
@VP	sited with long-term cultured OEC	39939
@VP	cultured OEC	39960
@VP	have lower levels of p75 expression than with short-term cultured cells	39973
@VP	cultured cells	40030
@VP	become senescent already after 3 -- 5 weeks in culture	40151
@VP	is extended for several weeks beyond senescence	40334
@VP	extended for several weeks beyond senescence	40337
@VP	can resume division	40387
@VP	resume division	40391
@VP	collected from the late passage cells -LRB- Pastrana et al. , 2007 -RRB-	41224
@VP	cultured OEC	41307
@VP	seems to be an important modulator of OEC-mediated axonal regeneration	41377
@VP	to be an important modulator of OEC-mediated axonal regeneration	41383
@VP	be an important modulator of OEC-mediated axonal regeneration	41386
@VP	cultured OEC	41537
@VP	secreted protein acidic rich in cystein	41707
@VP	has been identified in OEC conditioned medium -LRB- Au et al. , 2007 -RRB-	41763
@VP	been identified in OEC conditioned medium -LRB- Au et al. , 2007 -RRB-	41767
@VP	identified in OEC conditioned medium -LRB- Au et al. , 2007 -RRB-	41772
@VP	to stimulate axonal regeneration via laminin-1 and TGFβ signaling	41964
@VP	stimulate axonal regeneration via laminin-1 and TGFβ signaling	41967
@VP	cultured OEC	42238
@VP	performed in the latter study	42473
@VP	is detected in NGF and NT-3 levels	42638
@VP	detected in NGF and NT-3 levels	42641
@VP	to generate both neurons and OEC	42758
@VP	generate both neurons and OEC	42761
@VP	to produce BDNF	42808
@VP	produce BDNF	42811
@VP	rescue axotomized red nucleus neurons after SCI -LRB- Xiao et al. , 2005 -RRB-	42831
@VP	axotomized red nucleus neurons after SCI -LRB- Xiao et al. , 2005 -RRB-	42838
@VP	shown that neurotrophic factors could not only prevent retrograde degeneration	42923
@VP	could not only prevent retrograde degeneration	42955
@VP	prevent retrograde degeneration	42970
@VP	have been reported after OEC transplantation	43242
@VP	been reported after OEC transplantation	43247
@VP	reported after OEC transplantation	43252
@VP	have been found in the red nucleus	43468
@VP	been found in the red nucleus	43473
@VP	found in the red nucleus	43478
@VP	cultured a-OEC on rubrospinal neurons	43578
@VP	tracing	43698
@VP	inducing significant regenerative response after transplantation	44126
@VP	transected rat spinal cord -LRB- Lopez-Vales et al. , 2006 , 2007 -RRB-	44207
@VP	leaving all other OEC subtypes in the supernatant	44369
@VP	does not initially express p75 receptors	44509
@VP	express p75 receptors	44528
@VP	separated different subtypes of OEC which had marked neuroprotective effect	44721
@VP	had marked neuroprotective effect	44763
@VP	marked neuroprotective effect	44767
@VP	failed to promote axonal regrowth	44801
@VP	to promote axonal regrowth	44808
@VP	promote axonal regrowth	44811
@VP	could interfere with the processes of interaction between transplanted OEC	44904
@VP	interfere with the processes of interaction between transplanted OEC	44910
@VP	surrounding host cells including reactive astrocytes	44983
@VP	cultured a-OEC	45077
@VP	are less effective in rescuing rubrospinal neurons than b-OEC	45092
@VP	rescuing rubrospinal neurons than b-OEC	45114
@VP	are much more effective in stimulating axonal regrowth across the trauma zone	45158
@VP	stimulating axonal regrowth across the trauma zone	45185
@VP	promoting neuronal survival and axonal regeneration	45284
@VP	respond differently to neurotrophic factors	45336
@VP	axotomized neurons	45418
@VP	cultured OEC	45642
@VP	is associated with reduced rubrospinal sprouting	45655
@VP	associated with reduced rubrospinal sprouting	45658
@VP	reduced rubrospinal sprouting	45674
@VP	sprouting	45694
@VP	might affect the outcome of OEC transplantation	46150
@VP	affect the outcome of OEC transplantation	46156
